Fibrinogen	B-protein
activates	O
NF-kappa	B-protein
B	I-protein
transcription	I-protein
factors	I-protein
in	O
mononuclear	B-cell_type
phagocytes	I-cell_type
.	O

Adhesion	O
to	O
extracellular	O
matrices	O
is	O
known	O
to	O
modulate	O
leukocyte	O
activation	O
,	O
although	O
the	O
mechanisms	O
are	O
not	O
fully	O
understood	O
.	O

Mononuclear	B-cell_type
phagocytes	I-cell_type
are	O
exposed	O
to	O
fibrinous	O
provisional	O
matrix	O
throughout	O
migration	O
into	O
inflammatory	O
foci	O
,	O
so	O
this	O
study	O
was	O
undertaken	O
to	O
determine	O
whether	O
fibrinogen	O
triggers	O
activation	O
of	O
NF-kappa	B-protein
B	I-protein
transcription	I-protein
factors	I-protein
.	O

U937	B-cell_line
cells	I-cell_line
differentiated	O
with	O
PMA	O
in	O
nonadherent	B-cell_line
culture	I-cell_line
were	O
shown	O
to	O
express	O
two	O
fibrinogen-binding	B-protein
integrins	I-protein
,	O
predominately	O
CD11b/CD18	B-protein
,	O
and	O
to	O
a	O
lesser	O
extent	O
,	O
CD11c/CD18	B-protein
.	O

Cells	O
stimulated	O
with	O
fibrinogen	B-protein
(	O
10-100	O
microg/ml	O
)	O
/Mn2+	O
(	O
50	O
microM	O
)	O
for	O
2	O
h	O
were	O
examined	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O

NF-kappa	B-protein
B	I-protein
activation	O
,	O
minimal	O
in	O
unstimulated	B-cell_type
cells	I-cell_type
,	O
was	O
substantially	O
up-regulated	O
by	O
fibrinogen	B-protein
.	O

Fibrinogen	B-protein
also	O
caused	O
activation	O
of	O
AP-1	B-protein
,	O
but	O
not	O
SP1	B-protein
or	O
cAMP	B-protein
response	I-protein
element-binding	I-protein
protein	I-protein
(	I-protein
CREB	I-protein
)	I-protein
factors	I-protein
.	O

Blocking	O
mAbs	B-protein
against	O
CD18	B-protein
and	O
CD11b	B-protein
abrogated	O
fibrinogen	B-protein
-induced	O
NF-kappa	B-protein
B	I-protein
activation	O
.	O

To	O
determine	O
the	O
effects	O
on	O
transcriptional	O
regulation	O
,	O
U937	B-cell_line
cells	I-cell_line
were	O
transfected	O
with	O
a	O
plasmid	O
containing	O
the	O
HIV-1	B-DNA
enhancer	I-DNA
(	O
bearing	O
two	O
NF-kappa	B-DNA
B	I-DNA
sites	I-DNA
)	O
coupled	O
to	O
a	O
chloramphenicol	B-DNA
acetyltransferase	I-DNA
(	I-DNA
CAT	I-DNA
)	I-DNA
reporter	I-DNA
.	O

Cells	O
were	O
subsequently	O
stimulated	O
with	O
1	O
)	O
PMA	O
for	O
24	O
h	O
,	O
inducing	O
CAT	B-protein
activity	O
by	O
2.6-fold	O
,	O
2	O
)	O
fibrinogen	B-protein
/Mn2+	O
for	O
2	O
h	O
,	O
inducing	O
CAT	B-protein
activity	O
by	O
3.2-fold	O
,	O
or	O
3	O
)	O
costimulation	O
with	O
fibrinogen	B-protein
and	O
PMA	O
,	O
inducing	O
5.7-fold	O
the	O
CAT	B-protein
activity	O
induced	O
by	O
PMA	O
alone	O
.	O

We	O
conclude	O
that	O
contact	O
with	O
fibrinogen-derived	B-protein
proteins	I-protein
may	O
contribute	O
to	O
mononuclear	O
phagocyte	O
activation	O
by	O
signaling	O
through	O
CD11b/CD18	B-protein
,	O
resulting	O
in	O
selective	O
activation	O
of	O
transcriptional	B-protein
regulatory	I-protein
factors	I-protein
,	O
including	O
NF-kappa	B-protein
B	I-protein
.	O

x	NULL
Boldly	NULL
GolnVivo	NULL
``	NULL
``	NULL
BioLegend®	NULL
#	NULL
s	NULL
meJournal	NULL
of	NULL
Fibrinogen	NULL
Activates	NULL
NF-xB	NULL
Transcription	NULL
4D	NULL
Imnmunolo	NULL
gy	NULL
Factors	NULL
in	NULL
Mononuclear	NULL
Phagocytes	NULL
Robert	NULL
G.	NULL
Sitrin	NULL
,	NULL
Pauline	NULL
M.	NULL
Pan	NULL
,	NULL
Sujata	NULL
Srikanth	NULL
and	NULL
Robert	NULL
F.	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
Todd	NULL
IMI	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

J	NULL
Immunol	NULL
1998	NULL
;	NULL
161:1462-1470	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/3/1462	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
44	NULL
articles	NULL
,	NULL
19	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/161/3/1462	NULL
.	NULL

full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
Fibrinogen	NULL
Activates	NULL
NF-rB	NULL
Transcription	NULL
Factors	NULL
in	NULL
Mononuclear	NULL
Phagocytes	NULL
'	NULL
Robert	NULL
G.	NULL
Sitrin	NULL
,	NULL
``	NULL
*	NULL
Pauline	NULL
M.	NULL
Pan	NULL
,	NULL
*	NULL
Sujata	NULL
Srikanth	NULL
,	NULL
*	NULL
and	NULL
Robert	NULL
F.	NULL
Todd	NULL
III	NULL
'	NULL
Adhesion	NULL
to	NULL
extracellular	NULL
matrices	NULL
is	NULL
known	NULL
to	NULL
modulate	NULL
leukocyte	NULL
activation	NULL
,	NULL
although	NULL
the	NULL
mechanisms	NULL
are	NULL
not	NULL
fully	NULL
understood	NULL
.	NULL

Mononuclear	NULL
phagocytes	NULL
are	NULL
exposed	NULL
to	NULL
fibrinous	NULL
provisional	NULL
matrix	NULL
throughout	NULL
migration	NULL
into	NULL
inflammatory	NULL
foci	NULL
,	NULL
so	NULL
this	NULL
study	NULL
was	NULL
undertaken	NULL
to	NULL
determine	NULL
whether	NULL
fibrinogen	NULL
triggers	NULL
activation	NULL
of	NULL
NF-KB	NULL
transcription	NULL
factors	NULL
.	NULL

U937	NULL
cells	NULL
differentiated	NULL
with	NULL
PMA	NULL
in	NULL
nonadherent	NULL
culture	NULL
were	NULL
shown	NULL
to	NULL
express	NULL
two	NULL
fibrinogen-binding	NULL
integrins	NULL
,	NULL
predominately	NULL
CD11b/CD18	NULL
,	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
CD11c/CD18	NULL
.	NULL

Cells	NULL
stimulated	NULL
with	NULL
fibrinogen	NULL
(	NULL
10-100	NULL
pg/ml	NULL
)	NULL
/Mn*®*	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
for	NULL
2	NULL
h	NULL
were	NULL
examined	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

NF-xB	NULL
activation	NULL
,	NULL
minimal	NULL
in	NULL
unstimulated	NULL
cells	NULL
,	NULL
was	NULL
substantially	NULL
up-regulated	NULL
by	NULL
fibrinogen	NULL
.	NULL

Fibrinogen	NULL
also	NULL
caused	NULL
activation	NULL
of	NULL
AP-1	NULL
,	NULL
but	NULL
not	NULL
SP1	NULL
or	NULL
cAMP	NULL
response	NULL
element-binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
factors	NULL
.	NULL

Blocking	NULL
mAbs	NULL
against	NULL
CD18	NULL
and	NULL
CD11b	NULL
abrogated	NULL
fibrinogen-induced	NULL
NF-KB	NULL
activation	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
effects	NULL
on	NULL
transcriptional	NULL
regulation	NULL
,	NULL
U937	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
plasmid	NULL
containing	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
(	NULL
bearing	NULL
two	NULL
NF-KB	NULL
sites	NULL
)	NULL
coupled	NULL
to	NULL
a	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
.	NULL

Cells	NULL
were	NULL
subsequently	NULL
stimulated	NULL
with	NULL
1	NULL
)	NULL
PMA	NULL
for	NULL
24	NULL
b	NULL
,	NULL
inducing	NULL
CAT	NULL
activity	NULL
by	NULL
2.6-fold	NULL
,	NULL
2	NULL
)	NULL
fibrinogen/Mn**	NULL
for	NULL
2	NULL
b	NULL
,	NULL
inducing	NULL
CAT	NULL
activity	NULL
by	NULL
3.2-fold	NULL
,	NULL
or	NULL
3	NULL
)	NULL
costimulation	NULL
with	NULL
fibrinogen	NULL
and	NULL
PMA	NULL
,	NULL
inducing	NULL
5.7-fold	NULL
the	NULL
CAT	NULL
activity	NULL
induced	NULL
by	NULL
PMA	NULL
alone	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
contact	NULL
with	NULL
fibrinogen-derived	NULL
proteins	NULL
may	NULL
contribute	NULL
to	NULL
mononuclear	NULL
phagocyte	NULL
activation	NULL
by	NULL
signaling	NULL
through	NULL
CD11b/CD18	NULL
,	NULL
resulting	NULL
in	NULL
selective	NULL
activation	NULL
of	NULL
transcriptional	NULL
regulatory	NULL
factors	NULL
,	NULL
including	NULL
NF-KB	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1998	NULL
,	NULL
161	NULL
:	NULL
1462-1470.	NULL
they	NULL
respond	NULL
to	NULL
chemotaxins	NULL
and	NULL
emigrate	NULL
from	NULL
the	NULL
vas-	NULL
cular	NULL
space	NULL
into	NULL
inflammatory	NULL
foci	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

1-3	NULL
)	NULL
.	NULL

This	NULL
sequence	NULL
of	NULL
events	NULL
has	NULL
been	NULL
characterized	NULL
extensively	NULL
,	NULL
although	NULL
important	NULL
mechanisms	NULL
at	NULL
every	NULL
phase	NULL
of	NULL
this	NULL
process	NULL
remain	NULL
undefined	NULL
.	NULL

Under	NULL
conditions	NULL
of	NULL
shear	NULL
stress	NULL
,	NULL
selectins	NULL
initiate	NULL
contact	NULL
with	NULL
the	NULL
endothelium	NULL
,	NULL
producing	NULL
rolling	NULL
adhesion	NULL
,	NULL
followed	NULL
by	NULL
firm	NULL
adhesion	NULL
,	NULL
mediated	NULL
in	NULL
large	NULL
part	NULL
by	NULL
3	NULL
,	NULL
integrins	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
an	NULL
inflammatory	NULL
reaction	NULL
is	NULL
determined	NULL
by	NULL
both	NULL
the	NULL
extent	NULL
of	NULL
leukocyte	NULL
recruitment	NULL
and	NULL
the	NULL
proinflammatory	NULL
actions	NULL
of	NULL
the	NULL
migrating	NULL
leukocytes	NULL
.	NULL

Accordingly	NULL
,	NULL
the	NULL
coupling	NULL
mechanisms	NULL
that	NULL
integrate	NULL
leukocyte	NULL
recruitment	NULL
with	NULL
signaling	NULL
pathways	NULL
for	NULL
cellular	NULL
activation	NULL
have	NULL
received	NULL
considerable	NULL
attention	NULL
.	NULL

Clearly	NULL
,	NULL
leukocyte	NULL
activation	NULL
signaling	NULL
can	NULL
proceed	NULL
in	NULL
nonadherent	NULL
cells	NULL
,	NULL
but	NULL
engagement	NULL
of	NULL
adhesion	NULL
proteins	NULL
modifies	NULL
the	NULL
activation	NULL
process	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
monocyte	NULL
tethering	NULL
to	NULL
endothelial	NULL
cell	NULL
P-selectin	NULL
may	NULL
not	NULL
only	NULL
immobilize	NULL
the	NULL
cell	NULL
but	NULL
also	NULL
serve	NULL
as	NULL
a	NULL
potent	NULL
costimulus	NULL
for	NULL
secretion	NULL
of	NULL
monocyte	NULL
chemotactic	NULL
protein-1	NULL
and	NULL
TNF-a	NULL
in	NULL
association	NULL
with	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
regulatory	NULL
factors	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Engagement	NULL
of	NULL
B	NULL
,	NULL
integrins	NULL
can	NULL
trigger	NULL
activation	NULL
signaling	NULL
(	NULL
7	NULL
)	NULL
,	NULL
although	NULL
the	NULL
capacity	NULL
for	NULL
activation	NULL
signaling	NULL
directly	NULL
through	NULL
B	NULL
;	NULL
,	NULL
integrins	NULL
is	NULL
less	NULL
clearly	NULL
defined	NULL
(	NULL
5	NULL
)	NULL
.	NULL

CR3	NULL
(	NULL
Mac-1	NULL
,	NULL
ay	NULL
,	NULL
CD11bVCD18	NULL
)	NULL
,	NULL
a	NULL
B	NULL
,	NULL
integrin	NULL
critically	NULL
involved	NULL
in	NULL
adhesion	NULL
,	NULL
locomotion	NULL
,	NULL
chemotaxis	NULL
,	NULL
and	NULL
phagocytosis	NULL
,	NULL
serves	NULL
as	NULL
a	NULL
receptor	NULL
for	NULL
a	NULL
diverse	NULL
group	NULL
of	NULL
ligands	NULL
,	NULL
including	NULL
iC3b	NULL
,	NULL
ICAM-1	NULL
,	NULL
I	NULL
eukocytes	NULL
utilize	NULL
a	NULL
complex	NULL
array	NULL
of	NULL
adhesion	NULL
proteins	NULL
as	NULL
*Pulmonary	NULL
and	NULL
Critical	NULL
Care	NULL
Medicine	NULL
Division	NULL
and	NULL
*Hematology-Oncology	NULL
Divi-sion	NULL
,	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Michigan	NULL
,	NULL
Ann	NULL
Arbor	NULL
,	NULL
MI	NULL
48109	NULL
Received	NULL
for	NULL
publication	NULL
December	NULL
11	NULL
,	NULL
1997	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
March	NULL
25	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
HL53283	NULL
,	NULL
CA	NULL
39064	NULL
,	NULL
and	NULL
CA42246	NULL
.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Robert	NULL
G.	NULL
Sitrin	NULL
,	NULL
6301	NULL
MSRB	NULL
TII	NULL
,	NULL
Box	NULL
0642	NULL
,	NULL
1150	NULL
West	NULL
Medical	NULL
Center	NULL
Drive	NULL
,	NULL
University	NULL
of	NULL
Michigan	NULL
Medical	NULL
Center	NULL
,	NULL
Ann	NULL
Arbor	NULL
,	NULL
MI	NULL
48109	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
rsitrin	NULL
@	NULL
umich.edu	NULL
Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
bacterial	NULL
LPS	NULL
,	NULL
glucan	NULL
,	NULL
coagulation	NULL
factor	NULL
X	NULL
,	NULL
and	NULL
fibrinogen	NULL
(	NULL
5	NULL
,	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Fibrinogen	NULL
is	NULL
also	NULL
a	NULL
ligand	NULL
for	NULL
a	NULL
limited	NULL
number	NULL
of	NULL
other	NULL
adhesion	NULL
proteins	NULL
,	NULL
including	NULL
the	NULL
B	NULL
;	NULL
,	NULL
integrin	NULL
CR4	NULL
(	NULL
p150/95	NULL
,	NULL
CD11c/	NULL
CD18	NULL
)	NULL
,	NULL
«	NULL
,	NULL
;	NULL
,	NULL
and	NULL
platelet	NULL
GPIIb/IIIa	NULL
(	NULL
5	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Interactions	NULL
between	NULL
leukocytes	NULL
and	NULL
fibrinogen/fibrin	NULL
may	NULL
have	NULL
special	NULL
importance	NULL
,	NULL
since	NULL
leukocytes	NULL
commonly	NULL
encounter	NULL
provisional	NULL
matrices	NULL
rich	NULL
in	NULL
fibrinogen	NULL
and	NULL
fibrin	NULL
at	NULL
sites	NULL
of	NULL
inflammation	NULL
.	NULL

There	NULL
is	NULL
considerable	NULL
evidence	NULL
that	NULL
the	NULL
products	NULL
of	NULL
coagulation	NULL
and	NULL
fibrinolysis	NULL
profoundly	NULL
affect	NULL
many	NULL
facets	NULL
of	NULL
inflammatory	NULL
reactions	NULL
,	NULL
wound	NULL
heal-ing	NULL
,	NULL
and	NULL
fibrosis	NULL
(	NULL
11-13	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
it	NULL
is	NULL
well	NULL
established	NULL
that	NULL
contact	NULL
with	NULL
fibrinogen	NULL
or	NULL
fibrin	NULL
matrix	NULL
can	NULL
dramatically	NULL
alter	NULL
the	NULL
expression	NULL
of	NULL
proinflammatory	NULL
factors	NULL
such	NULL
as	NULL
TNF-a	NULL
@	NULL
,	NULL
IL-1	NULL
,	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
,	NULL
and	NULL
possibly	NULL
IL-8	NULL
in	NULL
vitro	NULL
(	NULL
12	NULL
,	NULL
14-17	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
precise	NULL
pathways	NULL
by	NULL
which	NULL
fibrinogen	NULL
and	NULL
its	NULL
derivatives	NULL
modulate	NULL
leukocyte	NULL
function	NULL
are	NULL
far	NULL
less	NULL
understood	NULL
.	NULL

One	NULL
plausible	NULL
mechanism	NULL
by	NULL
which	NULL
activation	NULL
signaling	NULL
through	NULL
fibrinogen/fibrin	NULL
could	NULL
broadly	NULL
influence	NULL
leukocyte	NULL
function	NULL
is	NULL
by	NULL
activation	NULL
of	NULL
pleiotropic	NULL
transcription	NULL
regulatory	NULL
proteins	NULL
.	NULL

NF-kB	NULL
is	NULL
a	NULL
particularly	NULL
important	NULL
candidate	NULL
,	NULL
since	NULL
its	NULL
activation	NULL
affects	NULL
a	NULL
broad	NULL
array	NULL
of	NULL
immediate-early	NULL
gene	NULL
products	NULL
,	NULL
including	NULL
TNF-	NULL
@	NULL
,	NULL
ILs	NULL
,	NULL
chemokines	NULL
,	NULL
and	NULL
colony	NULL
stimulating	NULL
factors	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

18-21	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
activation	NULL
has	NULL
been	NULL
demonstrated	NULL
by	NULL
engagement	NULL
of	NULL
other	NULL
adhesion	NULL
proteins	NULL
such	NULL
as	NULL
3	NULL
,	NULL
integrins	NULL
,	NULL
but	NULL
not	NULL
by	NULL
fibrinogen	NULL
binding	NULL
or	NULL
by	NULL
Ab	NULL
ligation	NULL
of	NULL
B	NULL
;	NULL
,	NULL
integrins	NULL
(	NULL
22	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
determine	NULL
whether	NULL
fibrinogen	NULL
could	NULL
trigger	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
other	NULL
transcription	NULL
regulatory	NULL
proteins	NULL
in	NULL
mononuclear	NULL
phagocytes	NULL
.	NULL

We	NULL
demonstrate	NULL
selective	NULL
activation	NULL
of	NULL
NF-kB	NULL
and	NULL
AP-1	NULL
by	NULL
fibrinogen	NULL
binding	NULL
in	NULL
PMA-differentiated	NULL
U937	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
it	NULL
is	NULL
shown	NULL
that	NULL
fibrinogen-triggered	NULL
NF-KB	NULL
activation	NULL
is	NULL
sufficient	NULL
to	NULL
serve	NULL
as	NULL
a	NULL
potent	NULL
stimulus	NULL
for	NULL
NF-	NULL
«	NULL
B-dependent	NULL
gene	NULL
transcription	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Reagents	NULL
Plasminogen-free	NULL
fibrinogen	NULL
(	NULL
>	NULL
95	NULL
%	NULL
purity	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Calbio-chem	NULL
(	NULL
La	NULL
Jolla	NULL
CA	NULL
)	NULL
.	NULL

LPS	NULL
from	NULL
Escherichia	NULL
coli	NULL
0111	NULL
:	NULL
B4	NULL
was	NULL
obtained	NULL
from	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
MO	NULL
.	NULL

Where	NULL
appropriate	NULL
,	NULL
all	NULL
reagents	NULL
used	NULL
during	NULL
0022-1767/98/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
cell	NULL
stimulation	NULL
were	NULL
pretreated	NULL
with	NULL
End-X	NULL
beads	NULL
(	NULL
Associates	NULL
of	NULL
Cape	NULL
Cod	NULL
,	NULL
Woods	NULL
Hole	NULL
,	NULL
MA	NULL
)	NULL
to	NULL
adsorb	NULL
any	NULL
contaminating	NULL
endotoxins	NULL
.	NULL

This	NULL
pretreatment	NULL
yielded	NULL
reagents	NULL
that	NULL
contained	NULL
less	NULL
than	NULL
0.01	NULL
endotoxin	NULL
U/ml	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
a	NULL
chromogenic	NULL
Limulus	NULL
amebocyte	NULL
lysate	NULL
assay	NULL
(	NULL
Associates	NULL
of	NULL
Cape	NULL
Cod	NULL
)	NULL
.	NULL

The	NULL
anti-B	NULL
;	NULL
integrin	NULL
mAbs	NULL
included	NULL
anti-CD18	NULL
mAb	NULL
(	NULL
TS1/18	NULL
;	NULL
IgG1	NULL
)	NULL
,	NULL
anti-CD11b	NULL
mAbs	NULL
(	NULL
clone	NULL
44	NULL
(	NULL
IgG2a	NULL
)	NULL
,	NULL
and	NULL
clone	NULL
OKM1	NULL
(	NULL
IgG2b	NULL
)	NULL
,	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
Thomas	NULL
Mercolino	NULL
,	NULL
Ortho	NULL
Diagnostic	NULL
Systems	NULL
,	NULL
Raritan	NULL
NJ	NULL
)	NULL
,	NULL
anti-CD11¢	NULL
mAbs	NULL
(	NULL
clone	NULL
3.9	NULL
(	NULL
IgG1	NULL
)	NULL
Leinco	NULL
Technologies	NULL
,	NULL
Ballwin	NULL
,	NULL
MO	NULL
,	NULL
and	NULL
clone	NULL
2E1	NULL
(	NULL
IgG2b	NULL
)	NULL
)	NULL
.	NULL

Isotype	NULL
matched	NULL
control	NULL
mAbs	NULL
were	NULL
obtained	NULL
from	NULL
Leinco	NULL
,	NULL
and	NULL
ICN	NULL
,	NULL
Costa	NULL
Mesa	NULL
,	NULL
CA	NULL
.	NULL

The	NULL
«	NULL
,	NULL
B	NULL
;	NULL
mAb	NULL
(	NULL
clone	NULL
LM	NULL
609	NULL
;	NULL
IgG1	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Chemicon	NULL
International	NULL
,	NULL
Temecula	NULL
,	NULL
CA	NULL
.	NULL

Anti-p65	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
c-Rel	NULL
Abs	NULL
were	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnologies	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
.	NULL

NF-KB	NULL
oligonucleotides	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
DNA	NULL
Core	NULL
Facility	NULL
,	NULL
University	NULL
of	NULL
Michigan	NULL
Medical	NULL
Center	NULL
.	NULL

Cell	NULL
culture	NULL
and	NULL
stimulation	NULL
The	NULL
U937	NULL
monocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
was	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
ATCC	NULL
,	NULL
Manassas	NULL
,	NULL
VA	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
propagated	NULL
in	NULL
75-cm	NULL
``	NULL
polystyrene	NULL
flasks	NULL
in	NULL
standard	NULL
medium	NULL
consisting	NULL
of	NULL
RPMI	NULL
1640	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
with	NULL
penicillin	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
,	NULL
streptomycin	NULL
(	NULL
100	NULL
pg/m	NULL
!	NULL

1	NULL
)	NULL
,	NULL
gentamicin	NULL
(	NULL
100	NULL
pg/ml	NULL
)	NULL
,	NULL
glutamine	NULL
(	NULL
2	NULL
mM	NULL
)	NULL
,	NULL
and	NULL
5	NULL
%	NULL
FBS	NULL
(	NULL
HyClone	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
.	NULL

To	NULL
induce	NULL
morphologic	NULL
and	NULL
functional	NULL
dif-ferentiation	NULL
,	NULL
the	NULL
U937	NULL
cells	NULL
were	NULL
transferred	NULL
to	NULL
1000-ml	NULL
Teflon	NULL
tissue	NULL
culture	NULL
bags	NULL
(	NULL
Baxter	NULL
Healthcare	NULL
,	NULL
Deerfield	NULL
,	NULL
IL	NULL
;	NULL
5	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
in	NULL
500	NULL
ml	NULL
of	NULL
medium	NULL
)	NULL
for	NULL
stimulation	NULL
with	NULL
0.5	NULL
nM	NULL
PMA	NULL
(	NULL
Sigma	NULL
)	NULL
in	NULL
nonadherent	NULL
culture	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
,	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
for	NULL
48	NULL
h.	NULL
The	NULL
cells	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
resuspended	NULL
in	NULL
20	NULL
mM	NULL
HEPES/140	NULL
mM	NULL
NaCl/2	NULL
mg/m	NULL
!	NULL

glucose/10	NULL
pg/ml	NULL
polymyxin	NULL
B	NULL
,	NULL
with	NULL
additives	NULL
as	NULL
indicated	NULL
,	NULL
and	NULL
returned	NULL
to	NULL
15-ml	NULL
Teflon	NULL
tissue	NULL
culture	NULL
bags	NULL
(	NULL
American	NULL
Fluoroseal	NULL
,	NULL
Columbia	NULL
,	NULL
MD	NULL
)	NULL
until	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
to	NULL
prepare	NULL
samples	NULL
for	NULL
EMSA	NULL
or	NULL
CAT	NULL
assays	NULL
.	NULL

Immunofluorescence	NULL
flow	NULL
cytometry	NULL
Cells	NULL
were	NULL
resuspended	NULL
in	NULL
staining	NULL
buffer	NULL
(	NULL
PBS	NULL
with	NULL
1	NULL
%	NULL
BSA	NULL
,	NULL
0.1	NULL
%	NULL
sodium	NULL
azide	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
and	NULL
incubated	NULL
with	NULL
the	NULL
relevant	NULL
primary	NULL
mAb	NULL
for	NULL
30	NULL
min	NULL
,	NULL
4°C	NULL
,	NULL
followed	NULL
by	NULL
R-phycoerythrin-conjugated	NULL
goat	NULL
anti-mouse	NULL
IgG	NULL
(	NULL
30	NULL
min	NULL
,	NULL
4°C	NULL
)	NULL
.	NULL

Immunofluorescence	NULL
flow	NULL
cytometric	NULL
analysis	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
Coulter	NULL
electronics	NULL
EPICSC	NULL
flow	NULL
cytometer	NULL
with	NULL
a	NULL
logarithmic	NULL
amplifier	NULL
(	NULL
Coulter	NULL
,	NULL
Miami	NULL
,	NULL
FL	NULL
;	NULL
Flow	NULL
Cytometry	NULL
Core	NULL
Facility	NULL
,	NULL
University	NULL
of	NULL
Michigan	NULL
Medical	NULL
Center	NULL
)	NULL
.	NULL

The	NULL
percent	NULL
of	NULL
positive	NULL
cells	NULL
was	NULL
determined	NULL
,	NULL
using	NULL
cells	NULL
stained	NULL
in	NULL
parallel	NULL
with	NULL
an	NULL
irrelevant	NULL
isotype-matched	NULL
primary	NULL
Ab	NULL
as	NULL
background	NULL
controls	NULL
.	NULL

EMSA	NULL
Activation	NULL
of	NULL
NF-KB	NULL
transcription	NULL
factors	NULL
was	NULL
measured	NULL
by	NULL
EMSA	NULL
(	NULL
adapt-ed	NULL
from	NULL
Ref	NULL
.	NULL

23	NULL
)	NULL
.	NULL

Nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Schre-iber	NULL
et	NULL
al	NULL
.	NULL

(	NULL
24	NULL
)	NULL
with	NULL
minor	NULL
modifications	NULL
.	NULL

After	NULL
a	NULL
preliminary	NULL
wash	NULL
in	NULL
Tris-buffered	NULL
saline	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
pelleted	NULL
and	NULL
washed	NULL
twice	NULL
in	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
with	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
PMSF	NULL
,	NULL
and	NULL
incubated	NULL
in	NULL
a	NULL
volume	NULL
at	NULL
0°C	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Five	NULL
microliters	NULL
of	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
was	NULL
then	NULL
added	NULL
,	NULL
and	NULL
the	NULL
nuclei	NULL
were	NULL
pelleted	NULL
at	NULL
15,000	NULL
X	NULL
g.	NULL
The	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
75	NULL
pl	NULL
of	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
with	NULL
0.4	NULL
M	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
nuclei	NULL
were	NULL
pelleted	NULL
once	NULL
again	NULL
at	NULL
15,000	NULL
X	NULL
g	NULL
,	NULL
4°C	NULL
,	NULL
and	NULL
the	NULL
supernatant	NULL
was	NULL
stored	NULL
at	NULL
-70°C	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
5-10	NULL
ug	NULL
protein	NULL
in	NULL
10	NULL
gl	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
,	NULL
25°C	NULL
,	NULL
with	NULL
10	NULL
pl	NULL
reaction	NULL
mixture	NULL
(	NULL
100	NULL
mM	NULL
Tris	NULL
Cl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
1	NULL
M	NULL
NaCl	NULL
,	NULL
50	NULL
mM	NULL
DTT	NULL
,	NULL
10	NULL
mM	NULL
EDTA	NULL
,	NULL
40	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mg/ml	NULL
BSA	NULL
(	NULL
nuclease	NULL
free	NULL
)	NULL
,	NULL
50	NULL
ng/ml	NULL
double-stranded	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
)	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
*°P	NULL
end-labeled	NULL
NF-KB	NULL
consensus	NULL
oligonucleotide	NULL
(	NULL
5'-AGT	NULL
TGA	NULL
GGG	NULL
GAC	NULL
TTT	NULL
CCC	NULL
AGG-3	NULL
'	NULL
)	NULL
(	NULL
6	NULL
)	NULL
,	NULL
or	NULL
AP-1	NULL
consensus	NULL
oligo	NULL
TTG	NULL
ATG	NULL
AGT	NULL
CAG	NULL
CCG	NULL
GAA-3	NULL
'	NULL
)	NULL
,	NULL
SP1	NULL
consensus	NULL
oligo	NULL
,	NULL
(	NULL
5-ATT	NULL
CGA	NULL
TCG	NULL
GGG	NULL
CGG	NULL
GGC	NULL
GAG	NULL
C-3	NULL
'	NULL
)	NULL
,	NULL
or	NULL
CREB	NULL
consensus	NULL
oligo	NULL
(	NULL
5-AGA	NULL
GAT	NULL
TGC	NULL
CTG	NULL
ACG	NULL
TCA	NULL
GAG	NULL
AGC	NULL
TAG-3	NULL
'	NULL
)	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnologies	NULL
)	NULL
.	NULL

The	NULL
reaction	NULL
mixture	NULL
was	NULL
run	NULL
on	NULL
a	NULL
4	NULL
%	NULL
PAGE	NULL
gel	NULL
in	NULL
high	NULL
ionic	NULL
strength	NULL
buffer	NULL
(	NULL
0.05	NULL
M	NULL
Tris	NULL
,	NULL
pH	NULL
8.5	NULL
,	NULL
380	NULL
mM	NULL
glycine	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
)	NULL
,	NULL
and	NULL
developed	NULL
with	NULL
a	NULL
Molecular	NULL
Dynamics	NULL
PhosphorImager	NULL
(	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
nuclear	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
to	NULL
the	NULL
labeled	NULL
oligonucleotide	NULL
was	NULL
demonstrated	NULL
by	NULL
visualizing	NULL
discrete	NULL
bands	NULL
of	NULL
DNA-protein	NULL
complexes	NULL
with	NULL
retarded	NULL
mobility	NULL
in	NULL
the	NULL
PAGE	NULL
gel	NULL
.	NULL

Binding	NULL
of	NULL
labeled	NULL
oligonucleotides	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
se-quence-specific	NULL
by	NULL
demonstrating	NULL
that	NULL
binding	NULL
was	NULL
1	NULL
)	NULL
blocked	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
and	NULL
2	NULL
)	NULL
unaffected	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
a	NULL
control	NULL
oligonucleotide	NULL
of	NULL
identical	NULL
length	NULL
and	NULL
base	NULL
composition	NULL
,	NULL
but	NULL
a	NULL
randomized	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
CREB	NULL
,	NULL
cAMP	NULL
response	NULL
element-binding	NULL
protein	NULL
;	NULL
LTR	NULL
,	NULL
long	NULL
terminal	NULL
repeat	NULL
;	NULL
Fbg	NULL
,	NULL
fibrinogen	NULL
;	NULL
wt	NULL
,	NULL
wild-type	NULL
.	NULL

1463	NULL
sequence	NULL
.	NULL

All	NULL
the	NULL
key	NULL
findings	NULL
shown	NULL
were	NULL
confirmed	NULL
with	NULL
EMSA	NULL
of	NULL
the	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
at	NULL
least	NULL
two	NULL
independently	NULL
run	NULL
experiments	NULL
.	NULL

Chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
assays	NULL
U937	NULL
cells	NULL
were	NULL
harvested	NULL
during	NULL
logarithmic	NULL
growth	NULL
and	NULL
transfected	NULL
with	NULL
a	NULL
plasmid	NULL
containing	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
(	NULL
bearing	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
)	NULL
linked	NULL
to	NULL
a	NULL
CAT	NULL
reporter	NULL
,	NULL
which	NULL
was	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
Gary	NULL
Nabel	NULL
,	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
University	NULL
of	NULL
Michigan	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Transfection	NULL
was	NULL
achieved	NULL
by	NULL
electroporation	NULL
,	NULL
using	NULL
15	NULL
ug	NULL
of	NULL
DNA	NULL
for	NULL
10	NULL
``	NULL
cells	NULL
at	NULL
300	NULL
V	NULL
and	NULL
1000	NULL
F.	NULL
The	NULL
cells	NULL
were	NULL
returned	NULL
to	NULL
culture	NULL
for	NULL
24	NULL
h	NULL
,	NULL
at	NULL
which	NULL
time	NULL
they	NULL
were	NULL
transferred	NULL
to	NULL
15-ml	NULL
Teflon	NULL
culture	NULL
bags	NULL
and	NULL
stimulated	NULL
either	NULL
with	NULL
PMA	NULL
(	NULL
0-5	NULL
nM	NULL
)	NULL
+	NULL
fibrinogen	NULL
(	NULL
50	NULL
ug/ml	NULL
!	NULL
)	NULL

for	NULL
24	NULL
h	NULL
,	NULL
or	NULL
fibrinogen	NULL
(	NULL
50	NULL
pg/ml	NULL
)	NULL
with	NULL
Mn**	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
for	NULL
2	NULL
h	NULL
,	NULL
in	NULL
serum-free	NULL
medium	NULL
(	NULL
Mac-SFM	NULL
,	NULL
Life	NULL
Technologies	NULL
)	NULL
.	NULL

Control	NULL
cells	NULL
cultured	NULL
in	NULL
parallel	NULL
were	NULL
mock	NULL
transfected	NULL
or	NULL
transfected	NULL
with	NULL
the	NULL
HIV-1-CAT	NULL
construct	NULL
and	NULL
cultured	NULL
in	NULL
medium	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
FBS	NULL
.	NULL

As	NULL
a	NULL
further	NULL
control	NULL
,	NULL
cells	NULL
were	NULL
also	NULL
transfected	NULL
with	NULL
a	NULL
«	NULL
B	NULL
mutant	NULL
HIV-1-CAT	NULL
plasmid	NULL
and	NULL
stimulated	NULL
with	NULL
PMA	NULL
+	NULL
fibrinogen	NULL
as	NULL
above	NULL
.	NULL

After	NULL
culture	NULL
for	NULL
24	NULL
h	NULL
,	NULL
cell	NULL
lysates	NULL
were	NULL
adjusted	NULL
for	NULL
protein	NULL
content	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
lysates	NULL
were	NULL
incubated	NULL
with	NULL
0.025	NULL
Ci	NULL
of	NULL
p-threo-	NULL
[	NULL
dichloroacetyl-1-'*C	NULL
]	NULL
chloramphenicol	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
and	NULL
1.38	NULL
mM	NULL
acetyl	NULL
coenzyme	NULL
A	NULL
at	NULL
37°C	NULL
for	NULL
24	NULL
h.	NULL
The	NULL
chloramphenicol	NULL
was	NULL
separated	NULL
from	NULL
its	NULL
acetylated	NULL
products	NULL
by	NULL
thin	NULL
layer	NULL
chromatog-raphy	NULL
(	NULL
TLC	NULL
)	NULL
.	NULL

The	NULL
TLC	NULL
plates	NULL
were	NULL
then	NULL
analyzed	NULL
with	NULL
a	NULL
PhosphorImager	NULL
,	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
acetylation	NULL
was	NULL
determined	NULL
with	NULL
Image	NULL
Quant	NULL
software	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

Results	NULL
PMA-induced	NULL
differentiation	NULL
of	NULL
U937	NULL
cells	NULL
Preliminary	NULL
experiments	NULL
verified	NULL
that	NULL
there	NULL
was	NULL
weak	NULL
NF-KB	NULL
activation	NULL
in	NULL
undifferentiated	NULL
U937	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
U937	NULL
cells	NULL
were	NULL
induced	NULL
to	NULL
differentiate	NULL
by	NULL
stimulation	NULL
with	NULL
a	NULL
low	NULL
concentration	NULL
of	NULL
PMA	NULL
(	NULL
0.5	NULL
nM	NULL
)	NULL
for	NULL
48	NULL
h.	NULL
Under	NULL
these	NULL
conditions	NULL
,	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
remained	NULL
very	NULL
low	NULL
,	NULL
provided	NULL
that	NULL
the	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
nonadherent	NULL
culture	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
whereas	NULL
contact	NULL
with	NULL
any	NULL
adhesive	NULL
surfaces	NULL
such	NULL
as	NULL
polystyrene	NULL
induced	NULL
significant	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
PMA-differentiated	NULL
cells	NULL
became	NULL
quite	NULL
responsive	NULL
to	NULL
LPS	NULL
,	NULL
demonstrating	NULL
a	NULL
strong	NULL
NF-KB	NULL
response	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Fibrinogen-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
PMA-differentiated	NULL
U937	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
fibrinogen	NULL
(	NULL
50	NULL
ug/m1	NULL
)	NULL
in	NULL
nonadherent	NULL
culture	NULL
for	NULL
2	NULL
h	NULL
,	NULL
at	NULL
which	NULL
time	NULL
nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
for	NULL
EMSA	NULL
assay	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
the	NULL
medium	NULL
was	NULL
supplemented	NULL
with	NULL
MnCl	NULL
,	NULL
(	NULL
50	NULL
M	NULL
)	NULL
to	NULL
ensure	NULL
that	NULL
cation-dependent	NULL
integrins	NULL
were	NULL
optimally	NULL
activated	NULL
(	NULL
27	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
14	NULL
,	NULL
fibrinogen	NULL
induced	NULL
substantial	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Mn*	NULL
'	NULL
,	NULL
even	NULL
in	NULL
comparison	NULL
with	NULL
LPS	NULL
stimulation	NULL
,	NULL
which	NULL
was	NULL
included	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
fibrinogen	NULL
was	NULL
dose	NULL
related	NULL
,	NULL
since	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
first	NULL
evident	NULL
with	NULL
as	NULL
little	NULL
as	NULL
10	NULL
pg/ml	NULL
,	NULL
with	NULL
a	NULL
substantial	NULL
response	NULL
occurring	NULL
with	NULL
25	NULL
pg/ml	NULL
,	NULL
a	NULL
maximal	NULL
response	NULL
with	NULL
50	NULL
pg/ml	NULL
,	NULL
and	NULL
a	NULL
plateau	NULL
effect	NULL
extending	NULL
through	NULL
100	NULL
pg/ml	NULL
!	NULL

(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Time	NULL
course	NULL
studies	NULL
indicate	NULL
that	NULL
fibrinogen-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
rapid	NULL
and	NULL
transient	NULL
,	NULL
with	NULL
a	NULL
maximal	NULL
response	NULL
after	NULL
1	NULL
and	NULL
2	NULL
h	NULL
of	NULL
stimulation	NULL
,	NULL
and	NULL
a	NULL
prompt	NULL
return	NULL
to	NULL
baseline	NULL
within	NULL
4	NULL
h.	NULL
By	NULL
contrast	NULL
,	NULL
LPS-induced	NULL
NF-KB	NULL
activation	NULL
was	NULL
somewhat	NULL
slower	NULL
to	NULL
evolve	NULL
,	NULL
with	NULL
a	NULL
maximal	NULL
response	NULL
developing	NULL
within	NULL
the	NULL
1-	NULL
and	NULL
2-h	NULL
time	NULL
points	NULL
.	NULL

Like	NULL
the	NULL
response	NULL
to	NULL
fibrinogen	NULL
,	NULL
NF-KB	NULL
activation	NULL
then	NULL
returned	NULL
to	NULL
baseline	NULL
within	NULL
4	NULL
h	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

All	NULL
these	NULL
experiments	NULL
were	NULL
conducted	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
polymyxin	NULL
B	NULL
to	NULL
block	NULL
the	NULL
effects	NULL
of	NULL
endotoxin	NULL
,	NULL
even	NULL
though	NULL
the	NULL
reagents	NULL
or	NULL
media	NULL
contained	NULL
no	NULL
more	NULL
than	NULL
0.01	NULL
EU/ml	NULL
.	NULL

This	NULL
corresponded	NULL
to	NULL
less	NULL
than	NULL
1	NULL
ng/ml	NULL
of	NULL
the	NULL
LPS	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
an	NULL
amount	NULL
that	NULL
produces	NULL
minimal	NULL
,	NULL
if	NULL
any	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

It	NULL
was	NULL
also	NULL
confirmed	NULL
that	NULL
polymyxin	NULL
B	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
produced	NULL
by	NULL
fibrinogen	NULL
but	NULL
significantly	NULL
reduced	NULL
the	NULL
magnitude	NULL
of	NULL
the	NULL
response	NULL
to	NULL
LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

In	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
1464	NULL
FIGURE	NULL
1	NULL
.	NULL

-	NULL
Fibrinogen-induced	NULL
NF-KB	NULL
activation	NULL
.	NULL

A	NULL
,	NULL
The	NULL
inset	NULL
(	NULL
right	NULL
)	NULL
demonstrates	NULL
representative	NULL
EMSA	NULL
assays	NULL
,	NULL
using	NULL
°°P-NF-	NULL
«	NULL
B	NULL
consensus	NULL
oligonucleotide	NULL
.	NULL

The	NULL
unbound	NULL
oligo	NULL
is	NULL
seen	NULL
at	NULL
the	NULL
leading	NULL
edge	NULL
,	NULL
and	NULL
the	NULL
regions	NULL
containing	NULL
discrete	NULL
bands	NULL
of	NULL
NF-kB	NULL
DNA-protein	NULL
complexes	NULL
(	NULL
bracketed	NULL
)	NULL
are	NULL
detailed	NULL
(	NULL
Jeff	NULL
)	NULL
.	NULL

The	NULL
unstimulated	NULL
cells	NULL
show	NULL
minimal	NULL
NF-KB	NULL
binding	NULL
proteins	NULL
,	NULL
while	NULL
fibrinogen	NULL
(	NULL
50	NULL
ug/ml	NULL
)	NULL
with	NULL
Mn**	NULL
(	NULL
50	NULL
wM	NULL
)	NULL
for	NULL
The	NULL
band	NULL
of	NULL
NF-B-specific	NULL
binding	NULL
(	NULL
demonstrated	NULL
in	NULL
FIBRINOGEN-INDUCED	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
m	NULL
A	NULL
‘	NULL
.	NULL

«	NULL
tah	NULL
(	NULL
C	NULL
e.	NULL
CONTROL	NULL
Fby/Mn	NULL
LPS	NULL
2	NULL
h	NULL
induced	NULL
substantial	NULL
NF-KB	NULL
activation	NULL
,	NULL
even	NULL
in	NULL
com-	NULL
B	NULL
u	NULL
|	NULL
|	NULL
-	NULL
n	NULL
parison	NULL
with	NULL
stimulation	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
for	NULL
2	NULL
h.	NULL
3	NULL
m	NULL
1	NULL
100	NULL
50	NULL
25	NULL
10	NULL
0	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
arrowhead	NULL
.	NULL

The	NULL
lower	NULL
band	NULL
(	NULL
*	NULL
)	NULL
,	NULL
which	NULL
varied	NULL
in	NULL
intensity	NULL
between	NULL
experiments	NULL
,	NULL
and	NULL
other	NULL
bands	NULL
outside	NULL
the	NULL
bracketed	NULL
area	NULL
represented	NULL
non-specific	NULL
oligo	NULL
binding	NULL
,	NULL
since	NULL
they	NULL
were	NULL
blocked	NULL
effectively	NULL
by	NULL
unlabeled	NULL
oligo	NULL
with	NULL
a	NULL
randomized	NULL
sequence	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Dose-response	NULL
relationship	NULL
between	NULL
the	NULL
concentration	NULL
of	NULL
fibrinogen	NULL
(	NULL
10-100	NULL
pg/ml	NULL
!	NULL
)	NULL

with	NULL
Mn**	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
.	NULL

A	NULL
detailed	NULL
view	NULL
of	NULL
the	NULL
EMSA	NULL
assay	NULL
is	NULL
C	NULL
shown	NULL
,	NULL
as	NULL
in	NULL
A	NULL
.	NULL

C	NULL
,	NULL
Time	NULL
course	NULL
of	NULL
fibrinogen-induced	NULL
NF-KB	NULL
activation	NULL
,	NULL
indicating	NULL
a	NULL
prominent	NULL
response	NULL
at	NULL
1	NULL
LPS	NULL
and	NULL
2	NULL
h	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
later	NULL
peak	NULL
observed	NULL
at	NULL
2	NULL
h	NULL
of	NULL
LPS-induced	NULL
activation	NULL
.	NULL

Neither	NULL
stimulus	NULL
induced	NULL
persistence	NULL
of	NULL
NF-KB	NULL
activation	NULL
extending	NULL
as	NULL
long	NULL
as	NULL
4	NULL
h.	NULL
Fbg	NULL
(	NULL
ug/ml	NULL
)	NULL
+	NULL
Mn	NULL
I	NULL
%	NULL
Fbg/Mn	NULL
Tak	NULL
l.	NULL
9	NULL
:	NULL
**	NULL
>	NULL
«	NULL
»	NULL
qm	NULL
Hours	NULL
0	NULL
0.5	NULL
1	NULL
2	NULL
3	NULL
4	NULL
addition	NULL
,	NULL
LPS-induced	NULL
NF-KB	NULL
activation	NULL
was	NULL
unaffected	NULL
by	NULL
the	NULL
absence	NULL
of	NULL
Mn**	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
while	NULL
Mn**~	NULL
was	NULL
necessary	NULL
for	NULL
fibrinogen	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
;	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
fibrinogen	NULL
activated	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
undifferentiated	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
;	NULL
see	NULL
below	NULL
)	NULL
,	NULL
while	NULL
,	NULL
as	NULL
noted	NULL
above	NULL
,	NULL
LPS	NULL
produced	NULL
a	NULL
weak	NULL
NF-	NULL
«	NULL
B	NULL
response	NULL
unless	NULL
the	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
PMA	NULL
.	NULL

These	NULL
distinctions	NULL
confirm	NULL
that	NULL
LPS	NULL
contamination	NULL
was	NULL
not	NULL
responsible	NULL
for	NULL
fibrinogen-induced	NULL
NF-KB	NULL
activation	NULL
.	NULL

Characterization	NULL
of	NULL
fibrinogen-induced	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
Experiments	NULL
were	NULL
next	NULL
performed	NULL
to	NULL
characterize	NULL
the	NULL
specific	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
induced	NULL
by	NULL
fibrinogen	NULL
.	NULL

First	NULL
,	NULL
cold	NULL
competition	NULL
studies	NULL
were	NULL
used	NULL
to	NULL
determine	NULL
which	NULL
protein-DNA	NULL
complexes	NULL
on	NULL
EMSA	NULL
are	NULL
sequence	NULL
specific	NULL
.	NULL

For	NULL
both	NULL
LPS-	NULL
and	NULL
fibrinogen-stimulated	NULL
cells	NULL
,	NULL
a	NULL
single	NULL
complex	NULL
was	NULL
formed	NULL
,	NULL
with	NULL
the	NULL
labeled	NULL
NF-KB	NULL
consensus	NULL
oligo	NULL
,	NULL
that	NULL
was	NULL
completely	NULL
blocked	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
cold	NULL
oligo	NULL
but	NULL
was	NULL
unaffected	NULL
by	NULL
a	NULL
cold	NULL
oligo	NULL
with	NULL
a	NULL
randomized	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

Antibody	NULL
supershifting	NULL
was	NULL
performed	NULL
to	NULL
further	NULL
characterize	NULL
the	NULL
composition	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

The	NULL
anti-p50	NULL
``	NULL
gem	NULL
ml	NULL
Control	NULL
Fbg/Mn	NULL
Polymyxin	NULL
B	NULL
=	NULL
+	NULL
=	NULL
+	NULL
=	NULL
+	NULL
FIGURE	NULL
2	NULL
.	NULL

Elimination	NULL
of	NULL
endotoxin	NULL
contamination	NULL
as	NULL
a	NULL
cause	NULL
of	NULL
fibrinogen-induced	NULL
NF-KB	NULL
activation	NULL
.	NULL

Fibrinogen-induced	NULL
NF-KB	NULL
activation	NULL
is	NULL
not	NULL
suppressed	NULL
by	NULL
inclusion	NULL
of	NULL
polymyxin	NULL
B	NULL
(	NULL
10	NULL
ug/ml	NULL
!	NULL
)	NULL

in	NULL
the	NULL
medium	NULL
,	NULL
while	NULL
NF-KB	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
is	NULL
significantly	NULL
reduced	NULL
.	NULL

Detailed	NULL
views	NULL
of	NULL
EMSA	NULL
assays	NULL
are	NULL
shown	NULL
as	NULL
in	NULL
Figure	NULL
1	NULL
,	NULL
with	NULL
the	NULL
band	NULL
of	NULL
NF-	NULL
«	NULL
B-specific	NULL
binding	NULL
indicated	NULL
by	NULL
the	NULL
arrowhead	NULL
.	NULL

Ab	NULL
,	NULL
which	NULL
cross-reacts	NULL
with	NULL
p52	NULL
,	NULL
eliminated	NULL
the	NULL
lower	NULL
portion	NULL
of	NULL
the	NULL
complex	NULL
,	NULL
and	NULL
slightly	NULL
attenuated	NULL
the	NULL
density	NULL
of	NULL
the	NULL
upper	NULL
portion	NULL
of	NULL
the	NULL
complex	NULL
.	NULL

The	NULL
anti-p65	NULL
(	NULL
Rel	NULL
A	NULL
)	NULL
Ab	NULL
,	NULL
which	NULL
cross-reacts	NULL
with	NULL
c-Rel	NULL
,	NULL
eliminated	NULL
the	NULL
upper	NULL
portion	NULL
of	NULL
this	NULL
complex	NULL
,	NULL
leaving	NULL
only	NULL
a	NULL
minor	NULL
band	NULL
constituting	NULL
the	NULL
lower	NULL
portion	NULL
of	NULL
the	NULL
complex	NULL
.	NULL

Finally	NULL
,	NULL
inclusion	NULL
of	NULL
both	NULL
Abs	NULL
virtually	NULL
eliminated	NULL
the	NULL
entire	NULL
NF-	NULL
«	NULL
B	NULL
band	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
demonstrated	NULL
band	NULL
of	NULL
NF-	NULL
«	NULL
B-specific	NULL
binding	NULL
stimulated	NULL
by	NULL
fibrinogen	NULL
is	NULL
comprised	NULL
of	NULL
a	NULL
mixture	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
forms	NULL
.	NULL

The	NULL
less	NULL
prominent	NULL
,	NULL
lower	NULL
portion	NULL
of	NULL
the	NULL
band	NULL
consists	NULL
of	NULL
dimers	NULL
containing	NULL
p50	NULL
and/or	NULL
p52	NULL
,	NULL
while	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
,	NULL
representing	NULL
the	NULL
upper	NULL
portion	NULL
of	NULL
the	NULL
band	NULL
,	NULL
consists	NULL
of	NULL
dimers	NULL
containing	NULL
Rel-A	NULL
and/or	NULL
c-Rel	NULL
.	NULL

Given	NULL
that	NULL
the	NULL
anti-p50/p52	NULL
Ab	NULL
slightly	NULL
reduced	NULL
the	NULL
density	NULL
of	NULL
the	NULL
upper	NULL
portion	NULL
of	NULL
the	NULL
band	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
some	NULL
heterodimers	NULL
containing	NULL
p50/p52	NULL
and	NULL
Rel-A/c-Rel	NULL
are	NULL
present	NULL
here	NULL
as	NULL
well	NULL
.	NULL

In	NULL
these	NULL
respects	NULL
,	NULL
the	NULL
NF-kB	NULL
binding	NULL
proteins	NULL
extracted	NULL
from	NULL
fibrinogen-stimulated	NULL
cells	NULL
appeared	NULL
identical	NULL
in	NULL
composition	NULL
to	NULL
those	NULL
extracted	NULL
from	NULL
LPS-treated	NULL
cells	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
a	NULL
distinct	NULL
class	NULL
of	NULL
NF-KB	NULL
sites	NULL
,	NULL
represented	NULL
in	NULL
the	NULL
IL-8	NULL
and	NULL
tissue	NULL
factor	NULL
genes	NULL
,	NULL
do	NULL
not	NULL
bind	NULL
p65/p50	NULL
heterodimers	NULL
but	NULL
selectively	NULL
bind	NULL
c-Rel/p65	NULL
dimers	NULL
(	NULL
28	NULL
)	NULL
,	NULL
offering	NULL
a	NULL
potential	NULL
mechanism	NULL
for	NULL
selective	NULL
gene	NULL
regulation	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
fibrinogen	NULL
and	NULL
LPS	NULL
induced	NULL
similar	NULL
proportions	NULL
of	NULL
p65	NULL
vs	NULL
c-Rel	NULL
,	NULL
supershifting	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
c-Rel-specific	NULL
Ab	NULL
that	NULL
does	NULL
not	NULL
cross-react	NULL
with	NULL
Rel-A	NULL
(	NULL
Santa	NULL
Cruz	NULL
No	NULL
.	NULL

se-1827	NULL
)	NULL
.	NULL

The	NULL
anti-p50/p52	NULL
Ab	NULL
was	NULL
always	NULL
included	NULL
in	NULL
these	NULL
experiments	NULL
so	NULL
only	NULL
the	NULL
p65/c-Rel	NULL
reactive	NULL
band	NULL
would	NULL
remain	NULL
.	NULL

The	NULL
density	NULL
of	NULL
the	NULL
p65/c-Rel	NULL
band	NULL
was	NULL
then	NULL
examined	NULL
with	NULL
and	NULL
without	NULL
supershifting	NULL
by	NULL
the	NULL
anti-c-Rel-specific	NULL
Ab	NULL
.	NULL

Because	NULL
the	NULL
c-Rel	NULL
Ab	NULL
only	NULL
partially	NULL
reduced	NULL
the	NULL
density	NULL
of	NULL
the	NULL
p65/c-Rel	NULL
band	NULL
,	NULL
the	NULL
results	NULL
were	NULL
analyzed	NULL
by	NULL
densitometry	NULL
,	NULL
using	NULL
ImageQuant	NULL
software	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

Supershifting	NULL
with	NULL
anti-c-Rel	NULL
reduced	NULL
the	NULL
density	NULL
of	NULL
the	NULL
p65/c-Rel	NULL
band	NULL
by	NULL
28.7	NULL
+	NULL
6.8	NULL
%	NULL
in	NULL
extracts	NULL
of	NULL
fibrinogen-stimulated	NULL
cells	NULL
,	NULL
and	NULL
by	NULL
27.5	NULL
+	NULL
6.1	NULL
%	NULL
in	NULL
extracts	NULL
of	NULL
LPS-stimulated	NULL
cells	NULL
,	NULL
indicating	NULL
that	NULL
fibrinogen	NULL
and	NULL
LPS	NULL
induce	NULL
activation	NULL
of	NULL
c-Rel-	NULL
vs	NULL
Rel-A-con-taining	NULL
dimers	NULL
in	NULL
similar	NULL
proportions	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
``	NULL
P	NULL
NF-	NULL
«	NULL
B	NULL
+	NULL
°P	NULL
NF-xB	NULL
ONF-xB	NULL
``	NULL
P-	NULL
NF-xB	NULL
+	NULL
{	NULL
Jeontrol	NULL
NF-1B	NULL
Fbg/Mn	NULL
_	NULL
LPS	NULL
Fbg/Mn	NULL
_	NULL
LPS	NULL
_	NULL
Fbg/Mn	NULL
LPS	NULL
Fbg/Mn	NULL
tﬂ	NULL
'	NULL
l	NULL
‘	NULL
C°	NULL
e	NULL
:	NULL
4s	NULL
a	NULL
«	NULL
lus	NULL
Ab	NULL
None	NULL
ps0	NULL
_	NULL
pés	NULL
p50	NULL
+p65	NULL
None	NULL
p50	NULL
_	NULL
p65	NULL
p50	NULL
+p65	NULL
FIGURE	NULL
3	NULL
.	NULL

Characterization	NULL
of	NULL
fibrinogen-induced	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
.	NULL

A	NULL
,	NULL
Cold	NULL
competition	NULL
of	NULL
EMSA	NULL
assays	NULL
of	NULL
nuclear	NULL
protein	NULL
extracts	NULL
prepared	NULL
from	NULL
fibrinogen/Mn**	NULL
or	NULL
LPS-stimulated	NULL
cells	NULL
.	NULL

Excess	NULL
unlabeled	NULL
NF-KB	NULL
oligo	NULL
completely	NULL
abrogated	NULL
formation	NULL
of	NULL
complexes	NULL
with	NULL
the	NULL
indicated	NULL
by	NULL
the	NULL
arrowhead	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
cold	NULL
competition	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
random	NULL
sequence	NULL
control	NULL
oligo	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
NF-	NULL
«	NULL
B-specific	NULL
complex	NULL
.	NULL

B	NULL
,	NULL
Ab	NULL
supershifting	NULL
.	NULL

Nuclear	NULL
protein	NULL
extracts	NULL
prepared	NULL
from	NULL
cells	NULL
stimulated	NULL
with	NULL
fibrinogen/Mn**	NULL
(	NULL
Zeff	NULL
)	NULL
or	NULL
LPS	NULL
(	NULL
right	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
*°P-NF-xB	NULL
oligo	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Abs	NULL
reactive	NULL
against	NULL
the	NULL
p50	NULL
and	NULL
p52	NULL
forms	NULL
(	NULL
anti-p50	NULL
)	NULL
,	NULL
the	NULL
p65	NULL
(	NULL
Rel	NULL
A	NULL
)	NULL
and	NULL
c-Rel	NULL
(	NULL
anti-p65	NULL
)	NULL
forms	NULL
,	NULL
or	NULL
both	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B-specific	NULL
complex	NULL
(	NULL
arrowheads	NULL
)	NULL
is	NULL
composed	NULL
of	NULL
a	NULL
mixture	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
forms	NULL
,	NULL
as	NULL
the	NULL
lower	NULL
portion	NULL
of	NULL
the	NULL
band	NULL
is	NULL
removed	NULL
by	NULL
the	NULL
anti-p50	NULL
Ab	NULL
,	NULL
while	NULL
the	NULL
more	NULL
prominent	NULL
upper	NULL
portion	NULL
of	NULL
the	NULL
band	NULL
is	NULL
removed	NULL
by	NULL
the	NULL
anti-p65	NULL
Ab	NULL
,	NULL
and	NULL
both	NULL
Abs	NULL
together	NULL
eliminate	NULL
the	NULL
band	NULL
almost	NULL
completely	NULL
.	NULL

Selectivity	NULL
of	NULL
NF-KB	NULL
activation	NULL
To	NULL
determine	NULL
whether	NULL
fibrinogen/Mn**	NULL
broadly	NULL
induces	NULL
activation	NULL
of	NULL
transcriptional	NULL
regulatory	NULL
factors	NULL
,	NULL
EMSA	NULL
assays	NULL
were	NULL
also	NULL
performed	NULL
using	NULL
consensus	NULL
oligonucleotides	NULL
for	NULL
AP-1	NULL
,	NULL
SP1	NULL
,	NULL
and	NULL
CONTROL	NULL
Fbg/Mn	NULL
LPS	NULL
AP-1	NULL
CONTROL	NULL
Fbg/Mn	NULL
-	NULL
LPS	NULL
<	NULL
»	NULL
ta	NULL
Cp	NULL
NF-	NULL
<	NULL
xB	NULL
1465	NULL
CREB	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
4	NULL
,	NULL
fibrinogen/Mn	NULL
``	NULL
*	NULL
produced	NULL
a	NULL
substantial	NULL
increase	NULL
in	NULL
AP-1	NULL
activation	NULL
that	NULL
was	NULL
highly	NULL
consistent	NULL
but	NULL
not	NULL
as	NULL
prominent	NULL
as	NULL
the	NULL
effect	NULL
produced	NULL
by	NULL
LPS	NULL
.	NULL

However	NULL
,	NULL
fibrinogen/Mn**	NULL
did	NULL
not	NULL
affect	NULL
binding	NULL
of	NULL
SP1	NULL
or	NULL
CREB	NULL
,	NULL
even	NULL
though	NULL
activation	NULL
of	NULL
both	NULL
factors	NULL
was	NULL
evident	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
LPS-stimulated	NULL
cells	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
signaling	NULL
through	NULL
fibrinogen/Mn	NULL
``	NULL
*	NULL
yields	NULL
a	NULL
limited	NULL
and	NULL
selective	NULL
array	NULL
of	NULL
activated	NULL
transcriptional	NULL
regulatory	NULL
factors	NULL
.	NULL

Nonetheless	NULL
,	NULL
the	NULL
broad	NULL
representation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
enhancer	NULL
regions	NULL
of	NULL
immediate-early	NULL
gene	NULL
products	NULL
and	NULL
other	NULL
proinflammatory	NULL
mediators	NULL
justifies	NULL
the	NULL
expectation	NULL
that	NULL
fibrinogen-induced	NULL
activation	NULL
of	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
families	NULL
should	NULL
have	NULL
wide-rang-ing	NULL
effects	NULL
on	NULL
expression	NULL
of	NULL
genes	NULL
that	NULL
are	NULL
tightly	NULL
regulated	NULL
during	NULL
inflammation	NULL
and	NULL
wound	NULL
healing	NULL
.	NULL

CR3	NULL
mediates	NULL
fibrinogen-induced	NULL
NF-KB	NULL
activation	NULL
One	NULL
of	NULL
the	NULL
more	NULL
notable	NULL
properties	NULL
of	NULL
fibrinogen-mediated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
that	NULL
the	NULL
effect	NULL
was	NULL
seen	NULL
only	NULL
in	NULL
Mn	NULL
``	NULL
'	NULL
-supplemented	NULL
medium	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Fibrinogen	NULL
(	NULL
50	NULL
pg/m	NULL
!	NULL
)	NULL

in	NULL
HEPES-buffered	NULL
saline/	NULL
glucose	NULL
without	NULL
Mn**	NULL
had	NULL
no	NULL
appreciable	NULL
effect	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Likewise	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
MnCl	NULL
,	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
alone	NULL
did	NULL
not	NULL
induce	NULL
NF-KB	NULL
activation	NULL
.	NULL

Preliminary	NULL
experiments	NULL
indicated	NULL
that	NULL
the	NULL
50	NULL
uM	NULL
concentration	NULL
of	NULL
MnCl	NULL
,	NULL
was	NULL
optimal	NULL
for	NULL
supporting	NULL
NF-B	NULL
activation	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
was	NULL
quite	NULL
similar	NULL
to	NULL
the	NULL
Mn**	NULL
concentration	NULL
that	NULL
maximally	NULL
activates	NULL
LFA-1	NULL
in	NULL
the	NULL
same	NULL
buffer	NULL
system	NULL
(	NULL
29	NULL
)	NULL
,	NULL
in	NULL
keeping	NULL
with	NULL
the	NULL
suggestion	NULL
that	NULL
the	NULL
requirement	NULL
for	NULL
Mn	NULL
*	NULL
reflected	NULL
the	NULL
conditions	NULL
that	NULL
optimized	NULL
ligation	NULL
to	NULL
fibrinogen-binding	NULL
integrins	NULL
.	NULL

Immunofluorescence	NULL
flow	NULL
cytometry	NULL
was	NULL
performed	NULL
to	NULL
assess	NULL
the	NULL
expression	NULL
of	NULL
integrins	NULL
capable	NULL
of	NULL
serving	NULL
as	NULL
fibrinogen	NULL
recep-tors	NULL
,	NULL
namely	NULL
CR3	NULL
(	NULL
CD11b/CD18	NULL
)	NULL
,	NULL
CR4	NULL
(	NULL
CD11c/CD18	NULL
)	NULL
,	NULL
and	NULL
a	NULL
,	NULL
$	NULL
B	NULL
;	NULL
.	NULL

GPIIb/IIIa	NULL
(	NULL
CD41b/CD61	NULL
)	NULL
,	NULL
which	NULL
shares	NULL
epitope	NULL
(	NULL
s	NULL
)	NULL
and	NULL
function	NULL
with	NULL
CR3	NULL
,	NULL
was	NULL
not	NULL
assessed	NULL
,	NULL
since	NULL
it	NULL
is	NULL
expressed	NULL
by	NULL
platelets	NULL
and	NULL
megakaryocytes	NULL
and	NULL
not	NULL
by	NULL
mononuclear	NULL
phagocytes	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Using	NULL
clone	NULL
44	NULL
anti-CD11b	NULL
mAb	NULL
,	NULL
it	NULL
was	NULL
determined	NULL
that	NULL
62	NULL
+	NULL
11	NULL
%	NULL
of	NULL
PMA-stimulated	NULL
cells	NULL
expressed	NULL
CR3	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
)	NULL
,	NULL
while	NULL
CR4	NULL
expression	NULL
,	NULL
although	NULL
significant	NULL
,	NULL
was	NULL
limited	NULL
to	NULL
34	NULL
+	NULL
7	NULL
%	NULL
of	NULL
cells	NULL
(	NULL
using	NULL
clone	NULL
3.9	NULL
anti-CD11c	NULL
mAb	NULL
)	NULL
.	NULL

The	NULL
staining	NULL
intensities	NULL
for	NULL
both	NULL
CD11b	NULL
and	NULL
CD11c	NULL
were	NULL
broadly	NULL
distributed	NULL
,	NULL
so	NULL
these	NULL
percentages	NULL
may	NULL
be	NULL
underestimates	NULL
,	NULL
excluding	NULL
cells	NULL
with	NULL
relatively	NULL
low	NULL
levels	NULL
of	NULL
integrin	NULL
expression	NULL
and	NULL
including	NULL
only	NULL
those	NULL
with	NULL
fluorescence	NULL
intensities	NULL
clearly	NULL
exceeding	NULL
control	NULL
cells	NULL
stained	NULL
with	NULL
irrelevant	NULL
primary	NULL
Abs	NULL
.	NULL

There	NULL
was	NULL
negligible	NULL
expression	NULL
of	NULL
«	NULL
,	NULL
f	NULL
,	NULL
(	NULL
1.5	NULL
+	NULL
0.3	NULL
%	NULL
positive	NULL
cells	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
urokinase	NULL
CONTROL	NULL
Fbg/Mn	NULL
LPS	NULL
SP1	NULL
oul	NULL
CONTROL	NULL
Fbg/Mn	NULL
CREB	NULL
FIGURE	NULL
4	NULL
.	NULL

-	NULL
Selectivity	NULL
of	NULL
NF-xB	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
fibrinogen/Mn®*	NULL
.	NULL

Nuclear	NULL
protein	NULL
extracts	NULL
prepared	NULL
from	NULL
1	NULL
)	NULL
unstimulated	NULL
control	NULL
cells	NULL
,	NULL
2	NULL
)	NULL
cells	NULL
stimulated	NULL
with	NULL
fibrinogen/Mn*	NULL
,	NULL
and	NULL
3	NULL
)	NULL
cells	NULL
stimulated	NULL
with	NULL
LPS	NULL
were	NULL
assayed	NULL
by	NULL
EMSA	NULL
,	NULL
using	NULL
consensus	NULL
oligonucleotides	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
SP1	NULL
,	NULL
and	NULL
CREB	NULL
.	NULL

Fibrinogen/Mn®*	NULL
increased	NULL
binding	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
oligonucleotides	NULL
but	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
SP1	NULL
or	NULL
CREB	NULL
,	NULL
even	NULL
though	NULL
both	NULL
of	NULL
these	NULL
were	NULL
induced	NULL
by	NULL
LPS	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
1466	NULL
Sole	NULL
|	NULL
|	NULL
Olin	NULL
:	NULL
CONTROL	NULL
__	NULL
Fbg/Mn	NULL
Fbg	NULL
Relo	NULL
on	NULL
CONTROL	NULL
Fbg/Mn	NULL
Mn	NULL
FIGURE	NULL
5	NULL
.	NULL

Fibrinogen-induced	NULL
NF-KB	NULL
activation	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
Mn	NULL
*	NULL
.	NULL

Detailed	NULL
views	NULL
of	NULL
EMSA	NULL
assays	NULL
are	NULL
shown	NULL
as	NULL
in	NULL
Figure	NULL
1	NULL
,	NULL
with	NULL
the	NULL
band	NULL
of	NULL
NF-	NULL
«	NULL
B-specific	NULL
binding	NULL
indicated	NULL
by	NULL
the	NULL
arrowhead	NULL
.	NULL

NF-KB	NULL
activation	NULL
was	NULL
induced	NULL
only	NULL
by	NULL
fibrinogen	NULL
(	NULL
50	NULL
pg/ml	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Mn**	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
,	NULL
and	NULL
not	NULL
by	NULL
either	NULL
fibrinogen	NULL
or	NULL
Mn**	NULL
alone	NULL
.	NULL

receptor	NULL
(	NULL
uPAR	NULL
;	NULL
CD87	NULL
)	NULL
was	NULL
also	NULL
assessed	NULL
,	NULL
since	NULL
uPAR	NULL
associates	NULL
with	NULL
many	NULL
integrins	NULL
,	NULL
including	NULL
CR3	NULL
and	NULL
CR4	NULL
,	NULL
and	NULL
this	NULL
association	NULL
strongly	NULL
influences	NULL
integrin-mediated	NULL
adhesion	NULL
,	NULL
including	NULL
CR3-mediated	NULL
adhesion	NULL
of	NULL
human	NULL
monocytes	NULL
to	NULL
fibrinogen	NULL
(	NULL
31-33	NULL
)	NULL
.	NULL

Detectable	NULL
uPAR	NULL
was	NULL
found	NULL
on	NULL
71	NULL
+	NULL
10	NULL
%	NULL
of	NULL
cells	NULL
,	NULL
confirming	NULL
their	NULL
availability	NULL
for	NULL
interactions	NULL
with	NULL
integrins	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
these	NULL
two	NULL
fibrinogen-binding	NULL
3	NULL
,	NULL
integrins	NULL
,	NULL
coupled	NULL
with	NULL
a	NULL
requirement	NULL
for	NULL
a	NULL
divalent	NULL
cation	NULL
(	NULL
Mn	NULL
'	NULL
)	NULL
,	NULL
which	NULL
is	NULL
characteristic	NULL
of	NULL
B	NULL
;	NULL
,	NULL
integrins	NULL
,	NULL
indirectly	NULL
implicated	NULL
CR3	NULL
and/or	NULL
CR4	NULL
as	NULL
candidate	NULL
receptors	NULL
responsible	NULL
for	NULL
fibrinogen-induced	NULL
NF-KB	NULL
.	NULL

Confirmatory	NULL
studies	NULL
were	NULL
next	NULL
performed	NULL
to	NULL
determine	NULL
which	NULL
integrin	NULL
(	NULL
s	NULL
)	NULL
might	NULL
be	NULL
responsible	NULL
for	NULL
fibrinogen-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
blocking	NULL
the	NULL
response	NULL
selectively	NULL
with	NULL
a	NULL
series	NULL
of	NULL
mAbs	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
mAb	NULL
(	NULL
100	NULL
ug/ml	NULL
)	NULL
for	NULL
30	NULL
min	NULL
before	NULL
adding	NULL
fibrinogen/Mn®*	NULL
.	NULL

Monoclonal	NULL
Abs	NULL
were	NULL
also	NULL
added	NULL
with	NULL
the	NULL
fibrinogen/Mn**	NULL
to	NULL
maintain	NULL
the	NULL
concentration	NULL
at	NULL
100	NULL
pg/ml	NULL
throughout	NULL
the	NULL
2-h	NULL
incubation	NULL
before	NULL
nuclear	NULL
protein	NULL
extraction	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
6	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
either	NULL
an	NULL
anti-CD18	NULL
mAb	NULL
(	NULL
clone	NULL
TS1/18	NULL
)	NULL
or	NULL
an	NULL
anti-CD11b	NULL
mAb	NULL
(	NULL
clone	NULL
OKM1	NULL
)	NULL
completely	NULL
abrogated	NULL
the	NULL
NF-KB	NULL
response	NULL
to	NULL
fibrinogen/Mn**	NULL
.	NULL

Control	NULL
mAbs	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Likewise	NULL
,	NULL
the	NULL
anti-CD11¢c	NULL
mAb	NULL
(	NULL
clone	NULL
2E1	NULL
)	NULL
was	NULL
ineffective	NULL
,	NULL
suggesting	NULL
that	NULL
CR3	NULL
,	NULL
and	NULL
not	NULL
CR4	NULL
,	NULL
is	NULL
the	NULL
receptor	NULL
predominately	NULL
responsible	NULL
for	NULL
fibrinogen-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
while	NULL
OKM1	NULL
blocked	NULL
NF-KB	NULL
activation	NULL
com-pletely	NULL
,	NULL
clone	NULL
44	NULL
,	NULL
an	NULL
anti-CD11b	NULL
mAb	NULL
that	NULL
reacts	NULL
with	NULL
an	NULL
epitope	NULL
located	NULL
in	NULL
the	NULL
I	NULL
domain	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
at	NULL
all	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
agrees	NULL
closely	NULL
with	NULL
prior	NULL
studies	NULL
indicating	NULL
that	NULL
OKM1	NULL
preferentially	NULL
blocks	NULL
binding	NULL
of	NULL
soluble	NULL
fibrinogen	NULL
to	NULL
CR3	NULL
,	NULL
while	NULL
I-domain	NULL
Abs	NULL
such	NULL
as	NULL
clone	NULL
44	NULL
preferentially	NULL
block	NULL
cellular	NULL
adhesion	NULL
to	NULL
immobilized	NULL
fibrinogen	NULL
(	NULL
8	NULL
,	NULL
9	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Augmented	NULL
transcription	NULL
of	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
by	NULL
costimulation	NULL
with	NULL
fibrinogen	NULL
To	NULL
determine	NULL
whether	NULL
stimulation	NULL
with	NULL
fibrinogen	NULL
is	NULL
sufficient	NULL
to	NULL
modulate	NULL
NF-	NULL
«	NULL
B-driven	NULL
gene	NULL
transcription	NULL
,	NULL
U937	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
an	NULL
HIV-1	NULL
enhancer-CAT	NULL
construct	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Prior	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
transcription	NULL
of	NULL
this	NULL
construct	NULL
is	NULL
refractory	NULL
to	NULL
further	NULL
modulation	NULL
once	NULL
the	NULL
cells	NULL
are	NULL
differentiated	NULL
into	NULL
a	NULL
more	NULL
mature	NULL
phenotype	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
these	NULL
experiments	NULL
were	NULL
performed	NULL
without	NULL
pretreating	NULL
the	NULL
cells	NULL
FIBRINOGEN-INDUCED	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
Control	NULL
Fbg/Mn	NULL
-	NULL
Control	NULL
Fbg/Mn	NULL
_	NULL
Control	NULL
Fbg/Mn	NULL
>	NULL
MW	NULL
ma	NULL
an	NULL
>	NULL
was	NULL
a	NULL
No	NULL
mAb	NULL
+	NULL
anti-CD18	NULL
mAb	NULL
_	NULL
+anti-CD11ib	NULL
mAb	NULL
Control	NULL
Fbg/Mn	NULL
m	NULL
#	NULL
~	NULL
:	NULL
as	NULL
+	NULL
anti-CD11c	NULL
mAb	NULL
Control	NULL
Fbg/Mn	NULL
+	NULL
Control	NULL
mAb	NULL
FIGURE	NULL
6	NULL
.	NULL

-	NULL
Blockade	NULL
of	NULL
fibrinogen-induced	NULL
NF-KB	NULL
activation	NULL
with	NULL
anti-CD11b/CD18	NULL
Abs	NULL
.	NULL

Monoclonal	NULL
Abs	NULL
against	NULL
CD18	NULL
(	NULL
TS1/18	NULL
)	NULL
and	NULL
CD11b	NULL
(	NULL
OKM	NULL
!	NULL

1	NULL
)	NULL
block	NULL
NF-B	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
fibrinogen/Mn*	NULL
*	NULL
.	NULL

The	NULL
anti-CD11¢c	NULL
mAb	NULL
(	NULL
2E1	NULL
)	NULL
did	NULL
not	NULL
inhibit	NULL
NF-KB	NULL
activation	NULL
.	NULL

Likewise	NULL
,	NULL
none	NULL
of	NULL
the	NULL
isotype-matched	NULL
control	NULL
mAbs	NULL
had	NULL
any	NULL
effect	NULL
(	NULL
only	NULL
the	NULL
IgG1	NULL
control	NULL
is	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
all	NULL
instances	NULL
,	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
100	NULL
ug/ml	NULL
concentrations	NULL
of	NULL
mAb	NULL
,	NULL
which	NULL
was	NULL
maintained	NULL
throughout	NULL
subsequent	NULL
stimulation	NULL
with	NULL
fibrinogen/Mn**	NULL
.	NULL

Detailed	NULL
views	NULL
of	NULL
EMSA	NULL
assays	NULL
are	NULL
as	NULL
shown	NULL
in	NULL
previous	NULL
figures	NULL
,	NULL
with	NULL
the	NULL
bands	NULL
of	NULL
NF-	NULL
«	NULL
B-specific	NULL
binding	NULL
indicated	NULL
by	NULL
the	NULL
arrowheads	NULL
.	NULL

with	NULL
PMA	NULL
.	NULL

Preliminary	NULL
experiments	NULL
confirmed	NULL
that	NULL
control	NULL
cells	NULL
(	NULL
transfected	NULL
,	NULL
but	NULL
otherwise	NULL
unstimulated	NULL
)	NULL
expressed	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
CAT	NULL
activity	NULL
minimally	NULL
above	NULL
the	NULL
background	NULL
activities	NULL
of	NULL
mock-transfected	NULL
cells	NULL
(	NULL
electroporated	NULL
,	NULL
no	NULL
plasmid	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
transfection	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B/CAT	NULL
plasmid	NULL
alone	NULL
resulted	NULL
in	NULL
little	NULL
cellular	NULL
activation	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Figure	NULL
74A	NULL
shows	NULL
that	NULL
stimulation	NULL
with	NULL
PMA	NULL
alone	NULL
for	NULL
24	NULL
h	NULL
had	NULL
only	NULL
a	NULL
limited	NULL
effect	NULL
on	NULL
CAT	NULL
activity	NULL
.	NULL

Only	NULL
the	NULL
highest	NULL
concentration	NULL
of	NULL
PMA	NULL
,	NULL
5	NULL
nM	NULL
,	NULL
produced	NULL
a	NULL
statistically	NULL
significant	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
(	NULL
2.6-fold	NULL
)	NULL
,	NULL
relative	NULL
to	NULL
unstimulated	NULL
controls	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
cells	NULL
stimulated	NULL
with	NULL
fibrinogen	NULL
(	NULL
50	NULL
ug/ml	NULL
)	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Mn	NULL
``	NULL
*	NULL
(	NULL
50	NULL
M	NULL
)	NULL
for	NULL
only	NULL
2	NULL
h	NULL
and	NULL
then	NULL
returned	NULL
to	NULL
serum-free	NULL
medium	NULL
for	NULL
the	NULL
remainder	NULL
of	NULL
a	NULL
24-h	NULL
culture	NULL
,	NULL
yielded	NULL
a	NULL
statistically	NULL
significant	NULL
increase	NULL
in	NULL
CAT	NULL
expression	NULL
,	NULL
3.2-fold	NULL
relative	NULL
to	NULL
unstimulated	NULL
controls	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Experiments	NULL
were	NULL
also	NULL
performed	NULL
to	NULL
determine	NULL
whether	NULL
fibrinogen	NULL
was	NULL
an	NULL
effective	NULL
costimulus	NULL
with	NULL
PMA	NULL
in	NULL
inducing	NULL
CAT	NULL
expression	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
,	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
varying	NULL
concentrations	NULL
of	NULL
PMA	NULL
+	NULL
fibrinogen	NULL
for	NULL
24	NULL
h	NULL
in	NULL
serum-free	NULL
medium	NULL
.	NULL

Mn**	NULL
was	NULL
omitted	NULL
from	NULL
these	NULL
experiments	NULL
since	NULL
concurrent	NULL
stimulation	NULL
with	NULL
PMA	NULL
was	NULL
deemed	NULL
adequate	NULL
to	NULL
activate	NULL
fibrinogen-binding	NULL
integrins	NULL
(	NULL
35	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
7B	NULL
,	NULL
costimulation	NULL
with	NULL
fibrinogen	NULL
significantly	NULL
enhanced	NULL
CAT	NULL
activity	NULL
for	NULL
all	NULL
concentrations	NULL
of	NULL
PMA	NULL
tested	NULL
.	NULL

The	NULL
peak	NULL
effect	NULL
of	NULL
fibrinogen	NULL
was	NULL
seen	NULL
with	NULL
0.5	NULL
nM	NULL
PMA	NULL
,	NULL
producing	NULL
5.7-fold	NULL
the	NULL
CAT	NULL
activity	NULL
achieved	NULL
by	NULL
stimulation	NULL
with	NULL
PMA	NULL
alone	NULL
.	NULL

This	NULL
protocol	NULL
was	NULL
repeated	NULL
with	NULL
cells	NULL
transfected	NULL
with	NULL
a	NULL
HIV-1	NULL
enhancer-CAT	NULL
construct	NULL
with	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
inactivated	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Under	NULL
these	NULL
circumstances	NULL
,	NULL
fibrinogen	NULL
costimulation	NULL
did	NULL
not	NULL
influence	NULL
CAT	NULL
expression	NULL
at	NULL
all	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
effect	NULL
is	NULL
clearly	NULL
NF-	NULL
«	NULL
B	NULL
dependent	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
wished	NULL
to	NULL
determine	NULL
whether	NULL
other	NULL
serum	NULL
proteins	NULL
could	NULL
serve	NULL
the	NULL
same	NULL
costimulatory	NULL
function	NULL
as	NULL
fibrinogen	NULL
.	NULL

Therefore	NULL
,	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B-intact	NULL
HIV	NULL
enhancer-CAT	NULL
construct	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
0.5	NULL
nM	NULL
)	NULL
with	NULL
and	NULL
without	NULL
5	NULL
%	NULL
FBS	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
serum	NULL
had	NULL
no	NULL
costimulatory	NULL
effect	NULL
on	NULL
CAT	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
fibrinogen	NULL
has	NULL
a	NULL
selective	NULL
effect	NULL
on	NULL
NF-	NULL
«	NULL
B-dependent	NULL
gene	NULL
expression	NULL
that	NULL
is	NULL
not	NULL
shared	NULL
broadly	NULL
by	NULL
other	NULL
circulating	NULL
proteins	NULL
.	NULL

It	NULL
was	NULL
notable	NULL
that	NULL
the	NULL
maximal	NULL
effect	NULL
of	NULL
fibrinogen	NULL
as	NULL
a	NULL
costimulus	NULL
with	NULL
PMA	NULL
,	NULL
a	NULL
5.7-fold	NULL
induction	NULL
,	NULL
was	NULL
roughly	NULL
twice	NULL
the	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
J	NULL
>	NULL
4	NULL
7	NULL
]	NULL
*	NULL
A	NULL
E	NULL
4	NULL
*	NULL
cie	NULL
O	NULL
6	NULL
C	NULL
3	NULL
E	NULL
2	NULL
&	NULL
4	NULL
-G	NULL
<	NULL
T	NULL
F—	NULL
<	NULL
I	NULL
4	NULL
]	NULL
o	NULL
0.50	NULL
5.0	NULL
Fbg/Mn	NULL
PMA	NULL
(	NULL
nM	NULL
)	NULL
8	NULL
-	NULL
*	NULL
s	NULL
|	NULL
35	NULL
C	NULL
o	NULL
4	NULL
O	NULL
6	NULL
4	NULL
J	NULL
0	NULL
$	NULL
&	NULL
0	NULL
5	NULL
3	NULL
44	NULL
.	NULL

3	NULL
>	NULL
*	NULL
Eo	NULL
{	NULL
=	NULL
2~	NULL
&	NULL
<	NULL
a	NULL
o	NULL
o	NULL
0.05	NULL
0.5	NULL
5.0	NULL
0.05	NULL
0.5	NULL
5.0	NULL
PMA	NULL
PMA	NULL
(	NULL
nM	NULL
)	NULL
PMA	NULL
(	NULL
nM	NULL
)	NULL
+	NULL
5	NULL
%	NULL
FBS	NULL
+	NULL
Fbg	NULL
+	NULL
Fbg	NULL
wt	NULL
HIV-1	NULL
LTR	NULL
__	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
+-	NULL
)	NULL
HIV-	NULL
LTR	NULL
FIGURE	NULL
7	NULL
.	NULL

A	NULL
,	NULL
NF-	NULL
«	NULL
B-dependent	NULL
transcriptional	NULL
regulation	NULL
by	NULL
PMA	NULL
and	NULL
fibrinogen/Mn**	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
the	NULL
wild-type	NULL
HIV-1/CAT	NULL
plasmid	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
0.05-5.0	NULL
nM	NULL
)	NULL
for	NULL
24	NULL
h	NULL
,	NULL
or	NULL
with	NULL
fibrinogen	NULL
(	NULL
50	NULL
ug/tal	NULL
)	NULL
/Mn®*	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
for	NULL
2	NULL
h	NULL
,	NULL
followed	NULL
by	NULL
incubation	NULL
in	NULL
serum-free	NULL
medium	NULL
for	NULL
22	NULL
h.	NULL
CAT	NULL
activities	NULL
of	NULL
the	NULL
cell	NULL
lysates	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
activities	NULL
of	NULL
transfected	NULL
,	NULL
but	NULL
otherwise	NULL
unstimulated	NULL
,	NULL
controls	NULL
.	NULL

PMA	NULL
induced	NULL
a	NULL
dose-depen-dent	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
that	NULL
reached	NULL
statistical	NULL
significance	NULL
only	NULL
with	NULL
the	NULL
5.0-nM	NULL
concentration	NULL
(	NULL
2.6-fold	NULL
)	NULL
.	NULL

Fibrinogen/Mn**	NULL
induced	NULL
a	NULL
significant	NULL
3.2-fold	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
.	NULL

One	NULL
sample	NULL
,	NULL
two-tailed	NULL
Student	NULL
's	NULL
7	NULL
tests	NULL
were	NULL
used	NULL
to	NULL
demonstrate	NULL
that	NULL
CAT	NULL
activities	NULL
were	NULL
#	NULL
100	NULL
%	NULL
of	NULL
control	NULL
.	NULL

*	NULL
p	NULL
<	NULL
0.02	NULL
,	NULL
n	NULL
=	NULL
4	NULL
.	NULL

B	NULL
,	NULL
left	NULL
,	NULL
Effects	NULL
of	NULL
stimulating	NULL
with	NULL
fibrinogen	NULL
(	NULL
50	NULL
pg/mly/Mn**	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
concurrently	NULL
with	NULL
PMA	NULL
(	NULL
0.05-5.0	NULL
nM	NULL
)	NULL
for	NULL
24	NULL
h.	NULL
Cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
HIV-1	NULL
LTR/CAT	NULL
construct	NULL
.	NULL

CAT	NULL
activities	NULL
of	NULL
cell	NULL
lysates	NULL
are	NULL
normalized	NULL
to	NULL
controls	NULL
stimulated	NULL
with	NULL
PMA	NULL
alone	NULL
(	NULL
without	NULL
fibrinogen/	NULL
Mn**	NULL
)	NULL
.	NULL

Costimulation	NULL
with	NULL
fibrinogen/Mn**	NULL
significantly	NULL
augmented	NULL
CAT	NULL
activities	NULL
at	NULL
all	NULL
PMA	NULL
concentrations	NULL
.	NULL

n	NULL
=	NULL
7	NULL
.	NULL

Middle	NULL
,	NULL
Costimulation	NULL
with	NULL
fibrinogen	NULL
(	NULL
50	NULL
ug/ml/Mn**	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
PMA-driven	NULL
CAT	NULL
activity	NULL
when	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
HIV-1	NULL
LTR/CAT	NULL
construct	NULL
bearing	NULL
inactivated	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
-	NULL
)	NULL
)	NULL
.	NULL

n	NULL
=	NULL
3	NULL
.	NULL

Right	NULL
,	NULL
FBS	NULL
(	NULL
5	NULL
%	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
as	NULL
a	NULL
costimulus	NULL
with	NULL
PMA	NULL
(	NULL
0.5	NULL
nM	NULL
)	NULL
,	NULL
using	NULL
wt	NULL
HIV-1	NULL
LTR/CAT-transfected	NULL
cells	NULL
.	NULL

n	NULL
=	NULL
7	NULL
.	NULL

Statistical	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
A	NULL
.	NULL

*	NULL
p	NULL
<	NULL
0.05.	NULL
maximal	NULL
effect	NULL
of	NULL
fibrinogen	NULL
as	NULL
a	NULL
lone	NULL
stimulus	NULL
(	NULL
3.2-fold	NULL
induc-tion	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
costimulation	NULL
with	NULL
PMA	NULL
and	NULL
fibrinogen	NULL
was	NULL
analyzed	NULL
by	NULL
EMSA	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
nuclear	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
at	NULL
2	NULL
h	NULL
parallel	NULL
the	NULL
demonstrated	NULL
effects	NULL
on	NULL
CAT	NULL
expression	NULL
at	NULL
24	NULL
h.	NULL
Previously	NULL
untreated	NULL
U937	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
5.0	NULL
and	NULL
0.5	NULL
nM	NULL
PMA	NULL
,	NULL
or	NULL
with	NULL
fibrinogen	NULL
(	NULL
50	NULL
pg/ml	NULL
)	NULL
/Mn	NULL
``	NULL
*	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
,	NULL
for	NULL
2	NULL
h.	NULL
PMA	NULL
alone	NULL
produced	NULL
only	NULL
a	NULL
modest	NULL
degree	NULL
of	NULL
1467	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
EMSA	NULL
assay	NULL
,	NULL
while	NULL
fibrinogen/Mn	NULL
``	NULL
*	NULL
produced	NULL
a	NULL
substantial	NULL
level	NULL
of	NULL
NF-KB	NULL
activation	NULL
,	NULL
even	NULL
in	NULL
undifferentiated	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
PMA	NULL
(	NULL
0.5	NULL
nM	NULL
)	NULL
and	NULL
fibrinogen/Mn*	NULL
*	NULL
reproducibly	NULL
yielded	NULL
a	NULL
level	NULL
of	NULL
NF-KB	NULL
activation	NULL
that	NULL
was	NULL
only	NULL
minimally	NULL
greater	NULL
than	NULL
fibrinogen/Mn®*	NULL
alone	NULL
.	NULL

Therefore	NULL
,	NULL
PMA	NULL
and	NULL
fibrinogen	NULL
do	NULL
not	NULL
have	NULL
additive	NULL
effects	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
that	NULL
can	NULL
account	NULL
for	NULL
the	NULL
enhanced	NULL
effect	NULL
of	NULL
fibrinogen	NULL
on	NULL
CAT	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
conditions	NULL
were	NULL
chosen	NULL
to	NULL
maximize	NULL
the	NULL
short-term	NULL
effects	NULL
of	NULL
PMA	NULL
and	NULL
fibrinogen/Mn**	NULL
,	NULL
so	NULL
it	NULL
remains	NULL
possible	NULL
that	NULL
costimulation	NULL
with	NULL
PMA	NULL
and	NULL
fibrinogen	NULL
over	NULL
24	NULL
h	NULL
affects	NULL
NF-KB	NULL
activation	NULL
in	NULL
ways	NULL
that	NULL
are	NULL
not	NULL
reflected	NULL
in	NULL
short	NULL
term	NULL
stimulation	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

It	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
the	NULL
costimulatory	NULL
effect	NULL
of	NULL
PMA	NULL
modulates	NULL
other	NULL
transcriptional	NULL
regulatory	NULL
factors	NULL
or	NULL
downstream	NULL
steps	NULL
in	NULL
CAT	NULL
synthesis	NULL
that	NULL
compliment	NULL
fibrinogen-induced	NULL
NF-KB	NULL
activation	NULL
.	NULL

Discussion	NULL
These	NULL
studies	NULL
demonstrate	NULL
that	NULL
fibrinogen	NULL
is	NULL
capable	NULL
of	NULL
triggering	NULL
substantial	NULL
activation	NULL
of	NULL
NF-KB	NULL
transcription	NULL
regulatory	NULL
factors	NULL
in	NULL
undifferentiated	NULL
and	NULL
PMA-differentiated	NULL
U937	NULL
mononuclear	NULL
phagocytes	NULL
.	NULL

The	NULL
composition	NULL
of	NULL
NF-	NULL
«	NULL
B-binding	NULL
proteins	NULL
closely	NULL
resembled	NULL
the	NULL
profile	NULL
induced	NULL
by	NULL
activation	NULL
with	NULL
LPS	NULL
,	NULL
in	NULL
that	NULL
dimers	NULL
containing	NULL
p65	NULL
and	NULL
c-REL	NULL
were	NULL
the	NULL
dominant	NULL
forms	NULL
,	NULL
with	NULL
a	NULL
minor	NULL
contribution	NULL
by	NULL
dimers	NULL
composed	NULL
of	NULL
p50	NULL
and	NULL
p52	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Under	NULL
the	NULL
conditions	NULL
employed	NULL
,	NULL
fibrinogen	NULL
was	NULL
able	NULL
to	NULL
produce	NULL
this	NULL
response	NULL
only	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Mn**	NULL
.	NULL

which	NULL
suggested	NULL
that	NULL
an	NULL
integrin	NULL
adhesion	NULL
protein	NULL
serves	NULL
as	NULL
the	NULL
fibrinogen	NULL
receptor	NULL
.	NULL

Many	NULL
prior	NULL
studies	NULL
have	NULL
indicated	NULL
that	NULL
CR3	NULL
(	NULL
Mac-1	NULL
;	NULL
CD11b/	NULL
CD18	NULL
)	NULL
,	NULL
a	NULL
B	NULL
,	NULL
integrin	NULL
,	NULL
is	NULL
the	NULL
dominant	NULL
fibrinogen-binding	NULL
receptor	NULL
on	NULL
mononuclear	NULL
phagocytes	NULL
(	NULL
8	NULL
,	NULL
9	NULL
,	NULL
36	NULL
)	NULL
,	NULL
while	NULL
another	NULL
;	NULL
integrin	NULL
,	NULL
CR4	NULL
(	NULL
150/95	NULL
;	NULL
CD11¢/CD18	NULL
)	NULL
,	NULL
can	NULL
also	NULL
bind	NULL
fibrinogen	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Flow	NULL
cytometry	NULL
experiments	NULL
indicate	NULL
that	NULL
the	NULL
PMA-differentiated	NULL
U937	NULL
cells	NULL
used	NULL
in	NULL
most	NULL
experiments	NULL
in	NULL
the	NULL
present	NULL
study	NULL
expressed	NULL
predominately	NULL
CR3	NULL
(	NULL
62	NULL
%	NULL
of	NULL
cells	NULL
)	NULL
,	NULL
although	NULL
there	NULL
was	NULL
an	NULL
appreciable	NULL
representation	NULL
of	NULL
CR4	NULL
as	NULL
well	NULL
(	NULL
34	NULL
%	NULL
of	NULL
cells	NULL
)	NULL
.	NULL

The	NULL
use	NULL
of	NULL
blocking	NULL
mAbs	NULL
further	NULL
verify	NULL
that	NULL
CR3	NULL
is	NULL
the	NULL
dominant	NULL
,	NULL
if	NULL
not	NULL
sole	NULL
,	NULL
receptor	NULL
responsible	NULL
for	NULL
fibrinogen-induced	NULL
NF-KB	NULL
activation	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
response	NULL
to	NULL
fibrinogen/Mn**	NULL
was	NULL
completely	NULL
negated	NULL
by	NULL
Abs	NULL
to	NULL
CD18	NULL
and	NULL
CD11b	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
fibrinogen-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
preserved	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-CD11¢c	NULL
mAb	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
a	NULL
blocking	NULL
effect	NULL
with	NULL
a	NULL
single	NULL
Ab	NULL
is	NULL
not	NULL
itself	NULL
convincing	NULL
,	NULL
but	NULL
,	NULL
together	NULL
with	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
residual	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-CD11b	NULL
mAb	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
CR4	NULL
contributed	NULL
significantly	NULL
to	NULL
fibrinogen-induced	NULL
NF-KB	NULL
activation	NULL
.	NULL

Given	NULL
the	NULL
overlap	NULL
in	NULL
ligand	NULL
specificities	NULL
and	NULL
the	NULL
structural	NULL
similarities	NULL
between	NULL
CR3	NULL
and	NULL
CR4	NULL
,	NULL
these	NULL
functional	NULL
dissimilarities	NULL
are	NULL
striking	NULL
and	NULL
offer	NULL
the	NULL
opportunity	NULL
to	NULL
further	NULL
explore	NULL
the	NULL
distinct	NULL
roles	NULL
these	NULL
integrins	NULL
may	NULL
play	NULL
in	NULL
adhesion/activation	NULL
coupling	NULL
.	NULL

Alternatively	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
level	NULL
of	NULL
CR4	NULL
expression	NULL
achieved	NULL
under	NULL
these	NULL
experimental	NULL
conditions	NULL
was	NULL
simply	NULL
insufficient	NULL
to	NULL
mediate	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

The	NULL
functional	NULL
implications	NULL
of	NULL
this	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
demonstrated	NULL
by	NULL
the	NULL
markedly	NULL
enhanced	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR-CAT	NULL
construct	NULL
in	NULL
response	NULL
to	NULL
fibrinogen	NULL
,	NULL
both	NULL
as	NULL
a	NULL
lone	NULL
stimulus	NULL
(	NULL
3.2-fold	NULL
the	NULL
activity	NULL
of	NULL
unstimulated	NULL
controls	NULL
;	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
and	NULL
as	NULL
a	NULL
potent	NULL
costimulus	NULL
with	NULL
PMA	NULL
,	NULL
where	NULL
the	NULL
resulting	NULL
CAT	NULL
activities	NULL
were	NULL
enhanced	NULL
by	NULL
fibrinogen	NULL
at	NULL
all	NULL
PMA	NULL
concentrations	NULL
tested	NULL
,	NULL
optimally	NULL
augmenting	NULL
CAT	NULL
expression	NULL
by	NULL
5.7-fold	NULL
.	NULL

None	NULL
of	NULL
these	NULL
effects	NULL
were	NULL
observed	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
construct	NULL
lacking	NULL
functional	NULL
NF-KB	NULL
sites	NULL
.	NULL

While	NULL
it	NULL
is	NULL
certainly	NULL
possible	NULL
that	NULL
both	NULL
PMA	NULL
and	NULL
fibrinogen	NULL
may	NULL
have	NULL
effects	NULL
other	NULL
than	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
that	NULL
enhance	NULL
expression	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR-CAT	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
1468	NULL
FIBRINOGEN-INDUCED	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
-ma	NULL
-	NULL
#	NULL
m	NULL
Control	NULL
PMA	NULL
PMA	NULL
5	NULL
nM	NULL
0.5	NULL
nM	NULL
Fbg/Mn	NULL
__	NULL
Fbg/Mn	NULL
+	NULL
PMA	NULL
0.5	NULL
nM	NULL
FIGURE	NULL
8	NULL
.	NULL

-	NULL
Effects	NULL
of	NULL
PMA	NULL
and	NULL
fibrinogen	NULL
on	NULL
NF-B	NULL
activation	NULL
.	NULL

Cells	NULL
(	NULL
without	NULL
prior	NULL
differentiation	NULL
with	NULL
PMA	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
5.0	NULL
and	NULL
0.5	NULL
nM	NULL
)	NULL
for	NULL
2	NULL
h	NULL
,	NULL
with	NULL
fibrinogen	NULL
(	NULL
50	NULL
ug/ml	NULL
)	NULL
/Mn®*	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
for	NULL
2	NULL
h	NULL
,	NULL
or	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
PMA	NULL
(	NULL
0.5	NULL
nM	NULL
)	NULL
+	NULL
fibrinogen	NULL
(	NULL
50	NULL
ug/ml	NULL
)	NULL
/Mn®*	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
for	NULL
2	NULL
h	NULL
,	NULL
and	NULL
assayed	NULL
by	NULL
EMSA	NULL
using	NULL
the	NULL
consensus	NULL
NF-KB	NULL
oligonucleotide	NULL
.	NULL

PMA	NULL
alone	NULL
induced	NULL
a	NULL
significant	NULL
degree	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
as	NULL
did	NULL
fibrinogen	NULL
(	NULL
50	NULL
pg/mal	NULL
)	NULL
/Mn**	NULL
(	NULL
50	NULL
M	NULL
)	NULL
in	NULL
undifferentiated	NULL
cells	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
PMA	NULL
and	NULL
fibrinogen	NULL
yielded	NULL
a	NULL
level	NULL
of	NULL
NF-KB	NULL
activation	NULL
that	NULL
was	NULL
only	NULL
marginally	NULL
greater	NULL
than	NULL
fibrinogen/Mn	NULL
``	NULL
*	NULL
alone	NULL
.	NULL

construct	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
the	NULL
effect	NULL
is	NULL
entirely	NULL
dependent	NULL
on	NULL
the	NULL
functionality	NULL
of	NULL
NF-KB	NULL
.	NULL

There	NULL
are	NULL
a	NULL
few	NULL
features	NULL
of	NULL
the	NULL
model	NULL
used	NULL
in	NULL
the	NULL
EMSA	NULL
experiments	NULL
(	NULL
PMA-pretreatment	NULL
of	NULL
U937	NULL
cells	NULL
for	NULL
48	NULL
h	NULL
)	NULL
that	NULL
merit	NULL
specific	NULL
comment	NULL
.	NULL

Preliminary	NULL
experiments	NULL
demonstrated	NULL
that	NULL
untreated	NULL
U937	NULL
cells	NULL
exhibited	NULL
poor	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
over	NULL
2	NULL
h	NULL
in	NULL
response	NULL
an	NULL
archetypal	NULL
agonist	NULL
such	NULL
as	NULL
LPS	NULL
.	NULL

Prior	NULL
work	NULL
has	NULL
shown	NULL
that	NULL
pretreating	NULL
U937	NULL
cells	NULL
with	NULL
PMA	NULL
for	NULL
24	NULL
h	NULL
induces	NULL
sustained	NULL
and	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
key	NULL
methodologic	NULL
difference	NULL
in	NULL
our	NULL
study	NULL
is	NULL
that	NULL
the	NULL
U937	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
strictly	NULL
nonadherent	NULL
culture	NULL
throughout	NULL
this	NULL
incubation	NULL
.	NULL

Preliminary	NULL
experiments	NULL
showed	NULL
that	NULL
PMA-pretreated	NULL
U937	NULL
cells	NULL
were	NULL
exquisitely	NULL
sensitive	NULL
to	NULL
even	NULL
transient	NULL
exposure	NULL
to	NULL
any	NULL
adhesive	NULL
surface	NULL
(	NULL
in-cluding	NULL
protein-coated	NULL
or	NULL
uncoated	NULL
plastic	NULL
)	NULL
,	NULL
resulting	NULL
in	NULL
near-max-imal	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
the	NULL
emergence	NULL
of	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
during	NULL
PMA-induced	NULL
differentiation	NULL
is	NULL
itself	NULL
critically	NULL
dependent	NULL
on	NULL
cellular	NULL
adhesion	NULL
.	NULL

The	NULL
very	NULL
low	NULL
baseline	NULL
expression	NULL
of	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
,	NULL
combined	NULL
with	NULL
a	NULL
differentiated	NULL
phenotype	NULL
(	NULL
with	NULL
relatively	NULL
high	NULL
levels	NULL
of	NULL
integrin	NULL
ex-pression	NULL
)	NULL
and	NULL
the	NULL
preserved	NULL
responsiveness	NULL
to	NULL
subsequent	NULL
stimulation	NULL
(	NULL
fibrinogen/Mn**	NULL
or	NULL
LPS	NULL
)	NULL
,	NULL
make	NULL
this	NULL
model	NULL
a	NULL
highly	NULL
attractive	NULL
one	NULL
for	NULL
studying	NULL
the	NULL
effects	NULL
of	NULL
integrins	NULL
on	NULL
gene	NULL
expression	NULL
in	NULL
mononuclear	NULL
phagocytes	NULL
.	NULL

Since	NULL
adhesion	NULL
to	NULL
fibrinogen-coated	NULL
flasks	NULL
produced	NULL
the	NULL
same	NULL
high	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
as	NULL
contact	NULL
with	NULL
uncoated	NULL
or	NULL
albumin-coated	NULL
plastic	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
the	NULL
model	NULL
is	NULL
limited	NULL
in	NULL
that	NULL
it	NULL
is	NULL
applicable	NULL
only	NULL
to	NULL
studying	NULL
soluble	NULL
counterligands	NULL
and	NULL
precluded	NULL
us	NULL
from	NULL
examining	NULL
the	NULL
effects	NULL
of	NULL
immobilized	NULL
fibrinogen	NULL
.	NULL

Another	NULL
particularly	NULL
interesting	NULL
feature	NULL
of	NULL
this	NULL
model	NULL
is	NULL
that	NULL
fibrinogen	NULL
induces	NULL
NF-KB	NULL
activation	NULL
even	NULL
while	NULL
the	NULL
cells	NULL
are	NULL
kept	NULL
meticulously	NULL
in	NULL
nonadherent	NULL
conditions	NULL
,	NULL
in	NULL
striking	NULL
contrast	NULL
to	NULL
prior	NULL
studies	NULL
suggesting	NULL
that	NULL
integrin-mediated	NULL
activation	NULL
signaling	NULL
requires	NULL
integrin	NULL
cross-linking	NULL
,	NULL
cellular	NULL
adhesion	NULL
,	NULL
and	NULL
cytoskeletal	NULL
rearrangement	NULL
(	NULL
5	NULL
)	NULL
.	NULL

We	NULL
can	NULL
not	NULL
dismiss	NULL
the	NULL
possibility	NULL
that	NULL
intercellular	NULL
contact	NULL
,	NULL
which	NULL
can	NULL
be	NULL
enhanced	NULL
by	NULL
fibrinogen	NULL
,	NULL
also	NULL
contributed	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
36	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
routinely	NULL
examined	NULL
after	NULL
fibrinogen	NULL
treatment	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
emerged	NULL
from	NULL
these	NULL
cultures	NULL
in	NULL
uniform	NULL
suspensions	NULL
.	NULL

Homo-typic	NULL
aggregation	NULL
was	NULL
not	NULL
observed	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
concept	NULL
that	NULL
leukocyte	NULL
integrins	NULL
can	NULL
serve	NULL
as	NULL
conduits	NULL
for	NULL
activation	NULL
signaling	NULL
first	NULL
emerged	NULL
from	NULL
observations	NULL
that	NULL
these	NULL
proteins	NULL
can	NULL
sample	NULL
the	NULL
extracellular	NULL
environment	NULL
for	NULL
extracellular	NULL
matrix	NULL
(	NULL
ECM	NULL
)	NULL
proteins	NULL
,	NULL
adjacent	NULL
cells	NULL
,	NULL
LPS	NULL
,	NULL
and	NULL
microbial	NULL
pathogens	NULL
,	NULL
and	NULL
,	NULL
through	NULL
transmembrane	NULL
domains	NULL
,	NULL
can	NULL
provide	NULL
a	NULL
physical	NULL
link	NULL
to	NULL
the	NULL
cytoskeleton	NULL
and	NULL
thereby	NULL
to	NULL
the	NULL
machinery	NULL
of	NULL
gene	NULL
expression	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Subsequent	NULL
studies	NULL
have	NULL
reinforced	NULL
this	NULL
concept	NULL
by	NULL
demonstrating	NULL
that	NULL
integrin	NULL
ligation	NULL
can	NULL
engage	NULL
various	NULL
pathways	NULL
of	NULL
intracellular	NULL
signal	NULL
transduction	NULL
.	NULL

Many	NULL
integrins	NULL
can	NULL
activate	NULL
the	NULL
Na	NULL
*/H	NULL
*	NULL
antiporter	NULL
with	NULL
a	NULL
resultant	NULL
increase	NULL
in	NULL
intracellular	NULL
pH	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Most	NULL
integrins	NULL
tested	NULL
,	NULL
including	NULL
CR3	NULL
,	NULL
can	NULL
also	NULL
trigger	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
concentration	NULL
of	NULL
intracellular	NULL
calcium	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Ab	NULL
binding	NULL
of	NULL
;	NULL
integrins	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
trigger	NULL
immediate-early	NULL
gene	NULL
expression	NULL
and	NULL
NF-KB	NULL
activation	NULL
(	NULL
7	NULL
,	NULL
22	NULL
)	NULL
,	NULL
but	NULL
a	NULL
similar	NULL
approach	NULL
to	NULL
signaling	NULL
through	NULL
B	NULL
;	NULL
,	NULL
integrins	NULL
was	NULL
unsuccessful	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Thus	NULL
far	NULL
,	NULL
evidence	NULL
for	NULL
activation	NULL
signaling	NULL
through	NULL
PB	NULL
;	NULL
,	NULL
integrins	NULL
has	NULL
been	NULL
indirect	NULL
or	NULL
limited	NULL
to	NULL
changes	NULL
in	NULL
early	NULL
signaling	NULL
mediators	NULL
such	NULL
as	NULL
intracellular	NULL
calcium	NULL
.	NULL

Contact	NULL
with	NULL
fibrinogen-related	NULL
proteins	NULL
can	NULL
induce	NULL
or	NULL
enhance	NULL
expression	NULL
of	NULL
immediate-early	NULL
genes	NULL
in	NULL
mononuclear	NULL
phagocytes	NULL
,	NULL
including	NULL
TNF-a	NULL
,	NULL
IL-1	NULL
$	NULL
,	NULL
and	NULL
tissue	NULL
factor	NULL
(	NULL
12	NULL
,	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

All	NULL
these	NULL
proteins	NULL
are	NULL
subject	NULL
to	NULL
regulation	NULL
by	NULL
NE-	NULL
«	NULL
B	NULL
,	NULL
but	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
not	NULL
demonstrated	NULL
directly	NULL
in	NULL
any	NULL
of	NULL
these	NULL
studies	NULL
.	NULL

However	NULL
,	NULL
recent	NULL
work	NULL
has	NULL
shown	NULL
that	NULL
CR3-transfected	NULL
fibroblasts	NULL
are	NULL
capable	NULL
of	NULL
NF-KB	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Local	NULL
activation	NULL
of	NULL
coagulation	NULL
and	NULL
fibrinolytic	NULL
pathways	NULL
,	NULL
virtually	NULL
ubiquitous	NULL
at	NULL
inflammatory	NULL
foci	NULL
,	NULL
is	NULL
deeply	NULL
insinuated	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
inflammatory	NULL
tissue	NULL
injury	NULL
and	NULL
repair	NULL
.	NULL

Fibrinogen	NULL
and	NULL
its	NULL
derivative	NULL
products	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
adhesion	NULL
,	NULL
spreading	NULL
,	NULL
and	NULL
movement	NULL
of	NULL
many	NULL
cell	NULL
types	NULL
involved	NULL
in	NULL
wound	NULL
repair	NULL
,	NULL
including	NULL
fibroblasts	NULL
,	NULL
endothelial	NULL
,	NULL
cells	NULL
,	NULL
and	NULL
epithelial	NULL
cells	NULL
(	NULL
38-40	NULL
)	NULL
.	NULL

It	NULL
is	NULL
also	NULL
expected	NULL
that	NULL
leukocytes	NULL
will	NULL
encounter	NULL
fibrinogen-related	NULL
proteins	NULL
at	NULL
virtually	NULL
every	NULL
phase	NULL
of	NULL
the	NULL
inflammatory	NULL
response	NULL
.	NULL

Circulating	NULL
monocytes	NULL
would	NULL
certainly	NULL
be	NULL
exposed	NULL
to	NULL
high	NULL
concentrations	NULL
of	NULL
fibrinogen	NULL
in	NULL
plasma	NULL
.	NULL

Monocytes	NULL
do	NULL
express	NULL
some	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
constitutively	NULL
(	NULL
41	NULL
)	NULL
,	NULL
which	NULL
is	NULL
clearly	NULL
not	NULL
maximal	NULL
,	NULL
and	NULL
monocytes	NULL
retain	NULL
responsiveness	NULL
to	NULL
fibrinogen	NULL
in	NULL
vitro	NULL
(	NULL
12	NULL
,	NULL
14-16	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
results	NULL
of	NULL
the	NULL
present	NULL
study	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
monocyte	NULL
CR3	NULL
is	NULL
relatively	NULL
incapable	NULL
of	NULL
mediating	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
until	NULL
activated	NULL
by	NULL
exposure	NULL
to	NULL
chemoattractants	NULL
,	NULL
early	NULL
adhesion	NULL
,	NULL
or	NULL
other	NULL
signals	NULL
.	NULL

These	NULL
and	NULL
other	NULL
factors	NULL
that	NULL
may	NULL
modulate	NULL
monocyte	NULL
responsiveness	NULL
to	NULL
plasma	NULL
fibrinogen	NULL
certainly	NULL
merit	NULL
future	NULL
study	NULL
.	NULL

Fibrin	NULL
and	NULL
platelet	NULL
deposits	NULL
accumulate	NULL
on	NULL
injured	NULL
endothelium	NULL
,	NULL
particularly	NULL
under	NULL
shear	NULL
stress	NULL
,	NULL
providing	NULL
an	NULL
adhesive	NULL
surface	NULL
for	NULL
activated	NULL
leukocytes	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Fibrinogen	NULL
can	NULL
significantly	NULL
enhance	NULL
adhesive	NULL
reactions	NULL
between	NULL
monocytes	NULL
and	NULL
endothelial	NULL
cells	NULL
by	NULL
acting	NULL
as	NULL
a	NULL
bridge	NULL
molecule	NULL
between	NULL
the	NULL
CR3	NULL
of	NULL
a	NULL
mononuclear	NULL
phagocyte	NULL
and	NULL
endothelial	NULL
ICAM-1	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Extravascular	NULL
fibrinogen	NULL
is	NULL
rapidly	NULL
converted	NULL
into	NULL
fibrin	NULL
deposits	NULL
that	NULL
persist	NULL
as	NULL
prominent	NULL
features	NULL
of	NULL
many	NULL
acute	NULL
and	NULL
chronic	NULL
inflammatory	NULL
reactions	NULL
.	NULL

Fibrinogen	NULL
may	NULL
gain	NULL
access	NULL
to	NULL
the	NULL
extravascular	NULL
compartment	NULL
either	NULL
by	NULL
exudation	NULL
of	NULL
circulating	NULL
fibrinogen	NULL
or	NULL
by	NULL
frank	NULL
hemorrhage	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
vivo	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Fibrinogen	NULL
can	NULL
also	NULL
be	NULL
synthesized	NULL
locally	NULL
by	NULL
epithelial	NULL
cells	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Leukocytes	NULL
contacting	NULL
fibrin-rich	NULL
matrices	NULL
may	NULL
be	NULL
directed	NULL
to	NULL
alter	NULL
production	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
(	NULL
12	NULL
,	NULL
15	NULL
)	NULL
,	NULL
and	NULL
,	NULL
in	NULL
addition	NULL
,	NULL
fibrin	NULL
degradation	NULL
products	NULL
can	NULL
amplify	NULL
the	NULL
inflammatory	NULL
reaction	NULL
by	NULL
serving	NULL
as	NULL
chemotaxins	NULL
(	NULL
45-47	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
studies	NULL
,	NULL
all	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
soluble	NULL
fibrinogen	NULL
,	NULL
so	NULL
it	NULL
will	NULL
be	NULL
necessary	NULL
to	NULL
determine	NULL
whether	NULL
its	NULL
derivative	NULL
forms	NULL
expected	NULL
at	NULL
sites	NULL
of	NULL
inflammation	NULL
,	NULL
including	NULL
fibrin	NULL
monomer	NULL
,	NULL
insoluble	NULL
fibrin	NULL
polymer	NULL
,	NULL
and	NULL
fibrin	NULL
degradation	NULL
products	NULL
,	NULL
are	NULL
equally	NULL
capable	NULL
of	NULL
activating	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
.	NULL

The	NULL
fibrinous	NULL
stroma	NULL
also	NULL
influences	NULL
the	NULL
architecture	NULL
of	NULL
inflamed	NULL
tissue	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
by	NULL
limiting	NULL
hemorrhage	NULL
,	NULL
entrapping	NULL
leukocytes	NULL
,	NULL
and	NULL
providing	NULL
a	NULL
provisional	NULL
matrix	NULL
for	NULL
the	NULL
ingrowth	NULL
of	NULL
fibroblasts	NULL
,	NULL
and	NULL
evidence	NULL
is	NULL
mounting	NULL
that	NULL
impaired	NULL
local	NULL
fibrinolysis	NULL
favors	NULL
the	NULL
development	NULL
of	NULL
excessive	NULL
fibrosis	NULL
rather	NULL
than	NULL
restoration	NULL
of	NULL
normal	NULL
tissue	NULL
structure	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
the	NULL
present	NULL
study	NULL
add	NULL
to	NULL
the	NULL
potential	NULL
mechanisms	NULL
by	NULL
which	NULL
local	NULL
fibrin	NULL
deposition	NULL
can	NULL
alter	NULL
the	NULL
course	NULL
of	NULL
inflammation	NULL
and	NULL
healing	NULL
.	NULL

The	NULL
broad	NULL
array	NULL
of	NULL
genes	NULL
that	NULL
are	NULL
regulated	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
factors	NULL
include	NULL
a	NULL
host	NULL
of	NULL
cytokines	NULL
that	NULL
participate	NULL
in	NULL
leukocyte	NULL
recruitment	NULL
and	NULL
activation	NULL
,	NULL
including	NULL
ILs	NULL
(	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
IL-12	NULL
)	NULL
,	NULL
TNF-a	NULL
,	NULL
chemokines	NULL
(	NULL
IL-8	NULL
,	NULL
growth-related	NULL
onco-gene	NULL
protein	NULL
(	NULL
Gro	NULL
)	NULL
a	NULL
,	NULL
-B	NULL
,	NULL
and	NULL
-y	NULL
,	NULL
macrophage	NULL
inflammatory	NULL
protein	NULL
(	NULL
MIP	NULL
)	NULL
-1	NULL
,	NULL
monocyte	NULL
chemotactic	NULL
protein	NULL
(	NULL
MCP	NULL
)	NULL
-1	NULL
)	NULL
,	NULL
induc-ible	NULL
nitric	NULL
oxide	NULL
synthase	NULL
(	NULL
iNOS	NULL
)	NULL
,	NULL
adhesion	NULL
proteins	NULL
(	NULL
ICAM-1	NULL
,	NULL
VCAM-1	NULL
)	NULL
,	NULL
and	NULL
viruses	NULL
(	NULL
HIV	NULL
,	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
,	NULL
and	NULL
ade-novirus	NULL
)	NULL
(	NULL
18	NULL
,	NULL
21	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
one	NULL
can	NULL
easily	NULL
hypothesize	NULL
that	NULL
the	NULL
same	NULL
fibrinogen-integrin	NULL
interaction	NULL
that	NULL
facilitates	NULL
immobilization	NULL
and	NULL
recruitment	NULL
of	NULL
leukocytes	NULL
can	NULL
,	NULL
by	NULL
triggering	NULL
NF-KB	NULL
activation	NULL
,	NULL
augment	NULL
the	NULL
production	NULL
of	NULL
cytokines	NULL
,	NULL
regulate	NULL
expression	NULL
of	NULL
adhesion	NULL
proteins	NULL
,	NULL
and	NULL
,	NULL
possibly	NULL
,	NULL
contribute	NULL
to	NULL
the	NULL
persistence	NULL
and	NULL
proliferation	NULL
of	NULL
viruses	NULL
.	NULL

Indeed	NULL
,	NULL
prior	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
HIV-infected	NULL
leukocytes	NULL
exhibit	NULL
enhanced	NULL
expression	NULL
of	NULL
CD11b	NULL
,	NULL
increased	NULL
adhesion	NULL
,	NULL
and	NULL
enhanced	NULL
replication	NULL
of	NULL
HIV	NULL
when	NULL
cells	NULL
adhere	NULL
to	NULL
specific	NULL
components	NULL
of	NULL
the	NULL
extracellular	NULL
matrix	NULL
(	NULL
49-51	NULL
)	NULL
.	NULL

It	NULL
is	NULL
well	NULL
recognized	NULL
that	NULL
HIV	NULL
replication	NULL
can	NULL
be	NULL
enhanced	NULL
by	NULL
the	NULL
effects	NULL
of	NULL
opportunistic	NULL
infections	NULL
,	NULL
and	NULL
local	NULL
deposition	NULL
of	NULL
fibrinogen-related	NULL
proteins	NULL
at	NULL
these	NULL
sites	NULL
of	NULL
infection	NULL
provide	NULL
yet	NULL
another	NULL
potentially	NULL
important	NULL
stimulus	NULL
by	NULL
which	NULL
this	NULL
may	NULL
occur	NULL
.	NULL

Lastly	NULL
,	NULL
NF-KB	NULL
factors	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
both	NULL
the	NULL
induction	NULL
and	NULL
prevention	NULL
of	NULL
apoptosis	NULL
,	NULL
suggesting	NULL
that	NULL
fibrinous	NULL
stroma	NULL
may	NULL
influence	NULL
the	NULL
longevity	NULL
of	NULL
leukocytes	NULL
and	NULL
parenchymal	NULL
cells	NULL
in	NULL
inflamed	NULL
or	NULL
healing	NULL
tissues	NULL
(	NULL
52	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
this	NULL
study	NULL
demonstrates	NULL
that	NULL
U937	NULL
mononuclear	NULL
phagocytes	NULL
react	NULL
to	NULL
exposure	NULL
to	NULL
fibrinogen	NULL
in	NULL
vitro	NULL
with	NULL
prompt	NULL
activation	NULL
of	NULL
pleiotropic	NULL
transcription	NULL
regulatory	NULL
factors	NULL
,	NULL
NF-kB	NULL
and	NULL
AP-1	NULL
.	NULL

The	NULL
NF-KB	NULL
response	NULL
is	NULL
mediated	NULL
by	NULL
CR3	NULL
but	NULL
does	NULL
not	NULL
require	NULL
cellular	NULL
adhesion	NULL
.	NULL

Finally	NULL
,	NULL
fibrinogen	NULL
,	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
concert	NULL
with	NULL
PMA	NULL
,	NULL
is	NULL
capable	NULL
of	NULL
supporting	NULL
substantially	NULL
enhanced	NULL
transcriptional	NULL
activity	NULL
of	NULL
a	NULL
NF-	NULL
«	NULL
B-regulated	NULL
gene	NULL
.	NULL

Fibrinogen-related	NULL
proteins	NULL
are	NULL
already	NULL
believed	NULL
to	NULL
be	NULL
important	NULL
participants	NULL
in	NULL
leukocyte	NULL
trafficking	NULL
and	NULL
tissue	NULL
remodeling	NULL
and	NULL
now	NULL
can	NULL
also	NULL
be	NULL
implicated	NULL
in	NULL
the	NULL
mechanisms	NULL
whereby	NULL
altered	NULL
coagulation/fibri-nolysis	NULL
homeostasis	NULL
in	NULL
inflamed	NULL
tissue	NULL
influences	NULL
activation	NULL
signaling	NULL
of	NULL
mononuclear	NULL
phagocytes	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Laura	NULL
Mayo-Bond	NULL
for	NULL
preparation	NULL
of	NULL
mAbs	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Albelda	NULL
,	NULL
S.	NULL
,	NULL
C.	NULL
Smith	NULL
,	NULL
and	NULL
P.	NULL
Ward	NULL
.	NULL

1994	NULL
.	NULL

Adhesion	NULL
molecules	NULL
and	NULL
inflammatory	NULL
injury	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

8:504	NULL
.	NULL

2	NULL
.	NULL

Beckhuizen	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
R.	NULL
van	NULL
Furth	NULL
.	NULL

1993	NULL
.	NULL

Monocyte	NULL
adherence	NULL
to	NULL
human	NULL
vascular	NULL
endothelium	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

54:363	NULL
.	NULL

3	NULL
.	NULL

Schleiffenbaum	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
J.	NULL
Fehr	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
and	NULL
selectivity	NULL
of	NULL
leukocyte	NULL
emigration	NULL
.	NULL

J	NULL
.	NULL

Lab	NULL
.	NULL

Clin	NULL
.	NULL

Med	NULL
.	NULL

127:151	NULL
.	NULL

4	NULL
.	NULL

Miyamoto	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Akiyama	NULL
,	NULL
and	NULL
K.	NULL
Yamada	NULL
.	NULL

1995	NULL
.	NULL

Synergistic	NULL
roles	NULL
for	NULL
receptor	NULL
occupancy	NULL
and	NULL
aggregation	NULL
in	NULL
integrin	NULL
transmembrane	NULL
function	NULL
.	NULL

Science	NULL
267:883	NULL
.	NULL

5	NULL
.	NULL

Rosales	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
R.	NULL
Juliano	NULL
.	NULL

1995	NULL
.	NULL

Signal	NULL
transduction	NULL
by	NULL
cell	NULL
adhesion	NULL
receptors	NULL
in	NULL
leukocytes	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

57:189	NULL
.	NULL

6	NULL
.	NULL

Weyrich	NULL
,	NULL
A.	NULL
,	NULL
T.	NULL
Mcintyre	NULL
,	NULL
R.	NULL
McEver	NULL
,	NULL
S.	NULL
Prescott	NULL
,	NULL
and	NULL
G.	NULL
Zimmerman	NULL
.	NULL

1995	NULL
.	NULL

Monocyte	NULL
tethering	NULL
by	NULL
P-selectin	NULL
regulates	NULL
monocyte	NULL
chemotactic	NULL
protein-1	NULL
and	NULL
TNF-a	NULL
secretion	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

95:2297	NULL
.	NULL

7	NULL
.	NULL

Yurochko	NULL
,	NULL
A.	NULL
,	NULL
D.	NULL
Liu	NULL
,	NULL
D.	NULL
Eierman	NULL
,	NULL
and	NULL
S.	NULL
Haskill	NULL
.	NULL

1992	NULL
.	NULL

Integrins	NULL
as	NULL
a	NULL
primary	NULL
signal	NULL
transduction	NULL
molecule	NULL
regulating	NULL
monocyte	NULL
immediate-early	NULL
gene	NULL
induc-tion	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:9034	NULL
.	NULL

8	NULL
.	NULL

Altieri	NULL
,	NULL
D.	NULL
,	NULL
F.	NULL
Agbanyo	NULL
,	NULL
J.	NULL
Plescia	NULL
,	NULL
M.	NULL
Ginsberg	NULL
,	NULL
T.	NULL
Edgington	NULL
,	NULL
and	NULL
E.	NULL
Plow	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
unique	NULL
recognition	NULL
site	NULL
mediates	NULL
the	NULL
interaction	NULL
of	NULL
fibrinogen	NULL
with	NULL
the	NULL
leukocyte	NULL
integrin	NULL
Mac-1	NULL
(	NULL
CD11b/CD18	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:12119	NULL
.	NULL

9	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

1469	NULL
Wright	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
Weitz	NULL
,	NULL
A.	NULL
Huang	NULL
,	NULL
S.	NULL
Levin	NULL
,	NULL
S.	NULL
Silverstein	NULL
,	NULL
and	NULL
J.	NULL
Loike	NULL
.	NULL

1988	NULL
.	NULL

Complement	NULL
receptor	NULL
type	NULL
three	NULL
(	NULL
CD11b/CD18	NULL
)	NULL
of	NULL
human	NULL
polymorphonuclear	NULL
leukocytes	NULL
recognizes	NULL
fibrinogen	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:7734.	NULL
.	NULL

Loike	NULL
,	NULL
J.	NULL
,	NULL
B.	NULL
Sodeik	NULL
,	NULL
L.	NULL
Cao	NULL
,	NULL
S.	NULL
Leucona	NULL
,	NULL
J.	NULL
Weitz	NULL
,	NULL
P.	NULL
Detmers	NULL
,	NULL
S.	NULL
Wright	NULL
,	NULL
and	NULL
S.	NULL
Silverstein	NULL
.	NULL

1991	NULL
.	NULL

CD11c/CD18	NULL
on	NULL
neutrophils	NULL
recognizes	NULL
a	NULL
domain	NULL
at	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
the	NULL
A	NULL
a	NULL
chain	NULL
of	NULL
fibrinogen	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:1044	NULL
.	NULL

Sitrin	NULL
,	NULL
R.	NULL
1992	NULL
.	NULL

Plasminogen	NULL
activation	NULL
in	NULL
the	NULL
injured	NULL
lung	NULL
:	NULL
pulmonology	NULL
does	NULL
not	NULL
recapitulate	NULL
hematology	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Resp	NULL
.	NULL

Cell	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

6:131	NULL
.	NULL

Perez	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
J.	NULL
Roman	NULL
.	NULL

1995	NULL
.	NULL

Fibrin	NULL
enhances	NULL
the	NULL
expression	NULL
of	NULL
IL-1	NULL
by	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:1879	NULL
.	NULL

Eitzman	NULL
,	NULL
D.	NULL
,	NULL
R.	NULL
McCoy	NULL
,	NULL
X.	NULL
Zheng	NULL
,	NULL
W.	NULL
Fay	NULL
,	NULL
T.	NULL
Shen	NULL
,	NULL
D.	NULL
Ginsburg	NULL
,	NULL
and	NULL
R.	NULL
Simon	NULL
.	NULL

1996	NULL
.	NULL

Bleomycin-induced	NULL
pulmonary	NULL
fibrosis	NULL
in	NULL
transgenic	NULL
mice	NULL
that	NULL
either	NULL
lack	NULL
or	NULL
overexpress	NULL
the	NULL
murine	NULL
plasminogen	NULL
activator	NULL
inhibitor-1	NULL
gene	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

97:232	NULL
.	NULL

Fan	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
T.	NULL
Edgington	NULL
.	NULL

1991	NULL
.	NULL

Coupling	NULL
of	NULL
the	NULL
adhesive	NULL
receptor	NULL
CD11b/CD18	NULL
to	NULL
functional	NULL
enhancement	NULL
of	NULL
effector	NULL
macrophage	NULL
tissue	NULL
factor	NULL
response	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

87:50	NULL
.	NULL

Fan	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
T.	NULL
Edgington	NULL
.	NULL

1993	NULL
.	NULL

Integrin	NULL
regulation	NULL
of	NULL
leukocyte	NULL
inflammatory	NULL
functions	NULL
:	NULL
CD11b/CD18	NULL
enhancement	NULL
of	NULL
the	NULL
TNF-	NULL
@	NULL
responses	NULL
of	NULL
monocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150:2972	NULL
.	NULL

Trezzini	NULL
,	NULL
C.	NULL
,	NULL
B.	NULL
Schiiepp	NULL
,	NULL
F.	NULL
Maly	NULL
,	NULL
and	NULL
T.	NULL
Jungi	NULL
.	NULL

1991	NULL
.	NULL

Evidence	NULL
that	NULL
exposure	NULL
to	NULL
fibrinogen	NULL
or	NULL
to	NULL
antibodies	NULL
directed	NULL
against	NULL
Mac-1	NULL
(	NULL
CD11b/CD18	NULL
;	NULL
CR3	NULL
)	NULL
modulates	NULL
human	NULL
monocyte	NULL
effector	NULL
functions	NULL
.	NULL

Brit	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

77:16	NULL
.	NULL

Pakianathan	NULL
,	NULL
D.	NULL
1995	NULL
.	NULL

Extracellular	NULL
matrix	NULL
proteins	NULL
and	NULL
leukocyte	NULL
function	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

57:699	NULL
.	NULL

Blackwell	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
J.	NULL
Christman	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
role	NULL
of	NULL
nuclear	NULL
factor-	NULL
B	NULL
in	NULL
cytokine	NULL
gene	NULL
regulation	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Cell	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

17:3	NULL
.	NULL

Baldwin	NULL
,	NULL
A	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
I	NULL
«	NULL
B	NULL
proteins	NULL
:	NULL
new	NULL
discoveries	NULL
and	NULL
insights	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:649	NULL
.	NULL

Grilli	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
J.-S.	NULL
Chiu	NULL
,	NULL
and	NULL
M.	NULL
Lenardo	NULL
.	NULL

1993	NULL
.	NULL

NF-	NULL
B	NULL
and	NULL
Rel	NULL
:	NULL
participants	NULL
in	NULL
a	NULL
multiform	NULL
transcriptional	NULL
regulatory	NULL
system	NULL
.	NULL

Int	NULL
.	NULL

Rev	NULL
.	NULL

Cytol	NULL
.	NULL

143:1	NULL
.	NULL

Miller	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
Ziegler-Heitbrock	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1993	NULL
.	NULL

Nuclear	NULL
factor	NULL
kappa	NULL
B	NULL
,	NULL
a	NULL
mediator	NULL
of	NULL
lipopolysaccharide	NULL
effects	NULL
.	NULL

Immunobiology	NULL
187	NULL
:	NULL
233	NULL
.	NULL

Lin	NULL
,	NULL
T.	NULL
,	NULL
C.	NULL
Rosales	NULL
,	NULL
K.	NULL
Mondal	NULL
,	NULL
J.	NULL
Bolen	NULL
,	NULL
S.	NULL
Haskill	NULL
,	NULL
and	NULL
R.	NULL
Juliano	NULL
.	NULL

1995	NULL
.	NULL

Integrin-mediated	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
cytokine	NULL
message	NULL
induction	NULL
in	NULL
monocytic	NULL
cells	NULL
:	NULL
a	NULL
possible	NULL
signaling	NULL
role	NULL
for	NULL
the	NULL
Syk	NULL
tyrosine	NULL
kinase	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:16189	NULL
.	NULL

Chodosh	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

1989	NULL
.	NULL

Mobility	NULL
shift	NULL
DNA-binding	NULL
assay	NULL
using	NULL
gel	NULL
electrophore-sis	NULL
.	NULL

In	NULL
Current	NULL
Protocols	NULL
in	NULL
Molecular	NULL
Biology	NULL
,	NULL
Vol	NULL
.	NULL

2	NULL
.	NULL

A.	NULL
Ausubel	NULL
,	NULL
R.	NULL
Brent	NULL
,	NULL
R.	NULL
E.	NULL
Kingston	NULL
,	NULL
D.	NULL
D.	NULL
Moore	NULL
,	NULL
J.	NULL
G.	NULL
Seidman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Smith	NULL
,	NULL
and	NULL
K.	NULL
Struhl	NULL
,	NULL
eds	NULL
.	NULL

Greene	NULL
Publishing	NULL
and	NULL
Wiley	NULL
Interscience	NULL
,	NULL
New	NULL
York	NULL
,	NULL
p.	NULL
12.2.1	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
M.	NULL
Muller	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1989	NULL
.	NULL

Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
``	NULL
mini	NULL
extracts	NULL
``	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:6419	NULL
.	NULL

Griffin	NULL
,	NULL
G.	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
T.	NULL
Folks	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
HIV	NULL
gene	NULL
expression	NULL
during	NULL
monocyte	NULL
differentiation	NULL
by	NULL
induction	NULL
of	NULL
NF-kB	NULL
.	NULL

Nature	NULL
339:70	NULL
.	NULL

Schmid	NULL
,	NULL
R.	NULL
,	NULL
N.	NULL
Perkins	NULL
,	NULL
C.	NULL
Duckett	NULL
,	NULL
P.	NULL
Andrews	NULL
,	NULL
and	NULL
G.	NULL
Nabel	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
an	NULL
NF-KB	NULL
subunit	NULL
which	NULL
stimulates	NULL
HIV	NULL
transcription	NULL
in	NULL
synergy	NULL
with	NULL
p65	NULL
.	NULL

Nature	NULL
352:733	NULL
.	NULL

Altieri	NULL
,	NULL
D.	NULL
1991	NULL
.	NULL

Occupancy	NULL
of	NULL
CD11b/CD18	NULL
(	NULL
Mac-1	NULL
)	NULL
divalent	NULL
ion	NULL
binding	NULL
site	NULL
(	NULL
s	NULL
)	NULL
induces	NULL
leukocyte	NULL
adhesion	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:1891	NULL
.	NULL

Octh	NULL
,	NULL
P.	NULL
,	NULL
G.	NULL
Parry	NULL
,	NULL
C.	NULL
Kunsch	NULL
,	NULL
P.	NULL
Nantermet	NULL
,	NULL
C.	NULL
Rosen	NULL
,	NULL
and	NULL
N.	NULL
Mackman	NULL
.	NULL

1994	NULL
.	NULL

Lipopolysaccharide	NULL
induction	NULL
of	NULL
tissue	NULL
factor	NULL
gene	NULL
expression	NULL
in	NULL
monocytic	NULL
cells	NULL
is	NULL
mediated	NULL
by	NULL
binding	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
to	NULL
a	NULL
«	NULL
B-like	NULL
site	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:3772	NULL
.	NULL

Dransfield	NULL
,	NULL
I.	NULL
,	NULL
C.	NULL
Cabanas	NULL
,	NULL
A.	NULL
Craig	NULL
,	NULL
and	NULL
N.	NULL
Hogg	NULL
.	NULL

1992	NULL
.	NULL

Divalent	NULL
cation	NULL
regulation	NULL
of	NULL
the	NULL
function	NULL
of	NULL
the	NULL
leukocyte	NULL
integrin	NULL
LFA-1	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

116:219	NULL
.	NULL

De	NULL
Nichilo	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
Shafren	NULL
,	NULL
W.	NULL
Carter	NULL
,	NULL
M.	NULL
Berndt	NULL
,	NULL
G.	NULL
Burns	NULL
,	NULL
and	NULL
A.	NULL
Boyd	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
common	NULL
epitope	NULL
on	NULL
platelet	NULL
integrin	NULL
&	NULL
,	NULL
,	NULL
(	NULL
glycoprotein	NULL
UbMIa	NULL
;	NULL
CD41b/	NULL
CD61	NULL
)	NULL
and	NULL
a	NULL
,	NULL
,	NULL
B	NULL
,	NULL
(	NULL
Mac-1	NULL
;	NULL
CD11b/CD18	NULL
)	NULL
detected	NULL
by	NULL
a	NULL
monoclonal	NULL
antibody	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:284	NULL
.	NULL

Sitrin	NULL
,	NULL
R.	NULL
,	NULL
R.	NULL
Todd	NULL
,	NULL
H.	NULL
Petty	NULL
,	NULL
T.	NULL
Brock	NULL
,	NULL
S.	NULL
Shollenberger	NULL
,	NULL
E.	NULL
Albrecht	NULL
,	NULL
and	NULL
M.	NULL
Gyetko	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
urokinase	NULL
receptor	NULL
(	NULL
CD87	NULL
)	NULL
facilitates	NULL
CD11b/CD18-me-diated	NULL
adhesion	NULL
of	NULL
human	NULL
monocytes	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

97:1942	NULL
.	NULL

Todd	NULL
,	NULL
R.	NULL
,	NULL
II	NULL
,	NULL
and	NULL
H.	NULL
Petty	NULL
.	NULL

1997	NULL
.	NULL

B	NULL
,	NULL
(	NULL
CD11/CD18	NULL
)	NULL
integrins	NULL
can	NULL
serve	NULL
as	NULL
signaling	NULL
partners	NULL
for	NULL
other	NULL
leukocyte	NULL
receptors	NULL
.	NULL

J	NULL
.	NULL

Lab	NULL
.	NULL

Clin	NULL
.	NULL

Med	NULL
.	NULL

129:492	NULL
.	NULL

Wei	NULL
,	NULL
Y.	NULL
,	NULL
M.	NULL
Lukashev	NULL
,	NULL
D.	NULL
Simon	NULL
,	NULL
S.	NULL
Bodary	NULL
,	NULL
S.	NULL
Rosenberg	NULL
,	NULL
M.	NULL
Doyle	NULL
,	NULL
and	NULL
H.	NULL
Chapman	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
of	NULL
integrin	NULL
function	NULL
by	NULL
the	NULL
urokinase	NULL
receptor	NULL
.	NULL

Science	NULL
273:1551	NULL
.	NULL

Diamond	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Garcia-Aguilar	NULL
,	NULL
J.	NULL
Bickford	NULL
,	NULL
A.	NULL
Corbi	NULL
,	NULL
and	NULL
T.	NULL
Springer	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
I	NULL
domain	NULL
is	NULL
a	NULL
major	NULL
recognition	NULL
site	NULL
on	NULL
the	NULL
leukocyte	NULL
integrin	NULL
Mac-1	NULL
(	NULL
CD11b/	NULL
CD18	NULL
)	NULL
for	NULL
four	NULL
distinct	NULL
adhesion	NULL
ligands	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

120:1031	NULL
.	NULL

Hogg	NULL
,	NULL
N.	NULL
,	NULL
J.	NULL
Harvey	NULL
,	NULL
C.	NULL
Cabanas	NULL
,	NULL
and	NULL
R.	NULL
Landis	NULL
.	NULL

1993	NULL
.	NULL

Control	NULL
of	NULL
leukocyte	NULL
integrin	NULL
activation	NULL
.	NULL

Am	NULL
.	NULL

Rev	NULL
.	NULL

Respir	NULL
.	NULL

Dis	NULL
.	NULL

158:855	NULL
.	NULL

Languino	NULL
,	NULL
L.	NULL
,	NULL
J.	NULL
Plescia	NULL
,	NULL
A.	NULL
Duperray	NULL
,	NULL
A.	NULL
Brian	NULL
,	NULL
E.	NULL
Plow	NULL
,	NULL
J.	NULL
Geltosky	NULL
,	NULL
and	NULL
D.	NULL
Altieri	NULL
.	NULL

1993	NULL
.	NULL

Fibrinogen	NULL
mediates	NULL
leukocyte	NULL
adhesion	NULL
to	NULL
vascular	NULL
endothe-lium	NULL
through	NULL
an	NULL
ICAM-1	NULL
dependent	NULL
pathway	NULL
.	NULL

Cell	NULL
73:1723	NULL
.	NULL

Ingalls	NULL
,	NULL
R.	NULL
,	NULL
M.	NULL
Amin	NULL
Arnaout	NULL
,	NULL
and	NULL
D.	NULL
Golenbock	NULL
.	NULL

1997	NULL
.	NULL

Outside-in	NULL
signaling	NULL
by	NULL
lipopolysaccharide	NULL
through	NULL
a	NULL
tailless	NULL
integrin	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:433	NULL
.	NULL

Brown	NULL
,	NULL
L.	NULL
,	NULL
N.	NULL
Lanir	NULL
,	NULL
J.	NULL
McDonagh	NULL
,	NULL
K.	NULL
Tognazzi	NULL
,	NULL
A.	NULL
Dvorak	NULL
,	NULL
and	NULL
H.	NULL
Dvorak	NULL
.	NULL

1993	NULL
.	NULL

Fibroblast	NULL
migration	NULL
in	NULL
fibrin	NULL
gel	NULL
matrices	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

142:273	NULL
.	NULL

Bunce	NULL
,	NULL
L.	NULL
,	NULL
L.	NULL
Sporn	NULL
,	NULL
and	NULL
C.	NULL
Francis	NULL
.	NULL

1992	NULL
.	NULL

Endothelial	NULL
cell	NULL
spreading	NULL
on	NULL
fibrin	NULL
requires	NULL
fibrinopeptide	NULL
B	NULL
cleavage	NULL
and	NULL
amino	NULL
acid	NULL
residues	NULL
15-42	NULL
of	NULL
the	NULL
3	NULL
chain	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

89:842	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
1470	NULL
40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

Donaldson	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
Mahan	NULL
,	NULL
D.	NULL
Amrani	NULL
,	NULL
and	NULL
J.	NULL
Hawiger	NULL
.	NULL

1989	NULL
.	NULL

Fibrinogen-mediated	NULL
epidermal	NULL
cell	NULL
migration	NULL
:	NULL
structural	NULL
correlates	NULL
for	NULL
fibrinogen	NULL
function	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Sci	NULL
.	NULL

94:101	NULL
.	NULL

Frankenberger	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Pforte	NULL
,	NULL
T.	NULL
Sternsdorf	NULL
,	NULL
B.	NULL
Passlick	NULL
,	NULL
P.	NULL
Bacuerle	NULL
,	NULL
and	NULL
H.W	NULL
.	NULL

Lioms	NULL
Ziegler-Heitbrock	NULL
.	NULL

1994	NULL
.	NULL

Constitutive	NULL
nuclear	NULL
NF-KB	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocyte	NULL
lineage	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

304:87	NULL
.	NULL

Kuijper	NULL
,	NULL
P.	NULL
,	NULL
H.	NULL
GallardoTorres	NULL
,	NULL
J.	NULL
Lammers	NULL
,	NULL
J.	NULL
Sixma	NULL
,	NULL
L.	NULL
Koenderman	NULL
,	NULL
and	NULL
J.	NULL
Zwaginga	NULL
.	NULL

1997	NULL
.	NULL

Platelet	NULL
and	NULL
fibrin	NULL
deposition	NULL
at	NULL
the	NULL
damaged	NULL
vessel	NULL
wall	NULL
:	NULL
cooperative	NULL
substrates	NULL
for	NULL
neutrohil	NULL
adhesion	NULL
under	NULL
flow	NULL
conditions	NULL
.	NULL

Blood	NULL
89:166	NULL
.	NULL

Shenkar	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
E.	NULL
Abraham	NULL
.	NULL

1997	NULL
.	NULL

Hemorrhage	NULL
induces	NULL
rapid	NULL
in	NULL
vivo	NULL
activation	NULL
of	NULL
CREB	NULL
and	NULL
NF-kB	NULL
in	NULL
murine	NULL
intraparenchymal	NULL
lung	NULL
mononuclear	NULL
cells	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Cell	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

16:145	NULL
.	NULL

Simpson-Haidaris	NULL
,	NULL
P.	NULL
1997	NULL
.	NULL

Induction	NULL
of	NULL
fibrinogen	NULL
biosynthesis	NULL
and	NULL
secretion	NULL
from	NULL
cultured	NULL
pulmonary	NULL
epithelial	NULL
cells	NULL
.	NULL

Blood	NULL
89:873	NULL
.	NULL

Leavell	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Peterson	NULL
,	NULL
and	NULL
T.	NULL
Gross	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
role	NULL
of	NULL
fibrin	NULL
degradation	NULL
products	NULL
in	NULL
neutrophil	NULL
recruitment	NULL
to	NULL
the	NULL
lung	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Cell	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

14:53	NULL
.	NULL

Kazura	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
Wenger	NULL
,	NULL
R.	NULL
Salata	NULL
,	NULL
A.	NULL
Budzynski	NULL
,	NULL
and	NULL
G.	NULL
Goldsmith	NULL
.	NULL

1989	NULL
.	NULL

Modulation	NULL
of	NULL
polymorphonuclear	NULL
leukocyte	NULL
microbicidal	NULL
activity	NULL
and	NULL
oxidative	NULL
metabolism	NULL
by	NULL
fibrinogen	NULL
degradation	NULL
products	NULL
D	NULL
and	NULL
E.	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

83:1916	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

FIBRINOGEN-INDUCED	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
Skogen	NULL
,	NULL
W.	NULL
,	NULL
R.	NULL
Senior	NULL
,	NULL
G.	NULL
Griffen	NULL
,	NULL
and	NULL
G.	NULL
Wilner	NULL
.	NULL

1988	NULL
.	NULL

Fibrinogen-derived	NULL
peptide	NULL
B	NULL
B	NULL
1-42	NULL
is	NULL
a	NULL
multidomained	NULL
neutrophil	NULL
chemoattractant	NULL
.	NULL

Blood	NULL
71	NULL
:	NULL
1745	NULL
.	NULL

Shu	NULL
,	NULL
H.	NULL
,	NULL
A.	NULL
Agranoff	NULL
,	NULL
E.	NULL
Nabel	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
C.	NULL
Duckett	NULL
,	NULL
A.	NULL
Neish	NULL
,	NULL
T.	NULL
Collins	NULL
,	NULL
and	NULL
G.	NULL
Nabel	NULL
.	NULL

1993	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule	NULL
1	NULL
gene	NULL
expression	NULL
by	NULL
specific	NULL
NF-kB	NULL
subunits	NULL
in	NULL
endothelial	NULL
and	NULL
epithelial	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:6283	NULL
.	NULL

Dhawan	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Vargo	NULL
,	NULL
and	NULL
M.	NULL
Meltzer	NULL
.	NULL

1992	NULL
.	NULL

Interactions	NULL
between	NULL
HIV-infected	NULL
monocytes	NULL
and	NULL
the	NULL
extracellular	NULL
matrix	NULL
:	NULL
increased	NULL
capacity	NULL
of	NULL
HIV-infected	NULL
monocytes	NULL
to	NULL
adhere	NULL
to	NULL
and	NULL
spread	NULL
on	NULL
extracellular	NULL
matrix	NULL
associated	NULL
with	NULL
changes	NULL
in	NULL
extent	NULL
of	NULL
virus	NULL
replication	NULL
and	NULL
cytopathic	NULL
effects	NULL
in	NULL
infected	NULL
cells	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

52:62	NULL
.	NULL

Palmer	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
A.	NULL
Hamblin	NULL
.	NULL

1993	NULL
.	NULL

Increased	NULL
CD11/CD18	NULL
expression	NULL
on	NULL
the	NULL
peripheral	NULL
blood	NULL
leucocytes	NULL
of	NULL
patients	NULL
with	NULL
HIV	NULL
disease	NULL
:	NULL
relationship	NULL
to	NULL
disease	NULL
severity	NULL
.	NULL

Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

93:344	NULL
.	NULL

Schnapp	NULL
,	NULL
L.	NULL
,	NULL
Y.	NULL
Wang	NULL
,	NULL
A.	NULL
Mosoian	NULL
,	NULL
P.	NULL
Klotman	NULL
,	NULL
and	NULL
M.	NULL
Klotman	NULL
.	NULL

1997	NULL
.	NULL

Role	NULL
of	NULL
adhesion	NULL
in	NULL
HIV	NULL
replication	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Crit	NULL
.	NULL

Care	NULL
Med	NULL
.	NULL

155	NULL
:	NULL
A15	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1996	NULL
.	NULL

NF-kB	NULL
:	NULL
ten	NULL
years	NULL
after	NULL
.	NULL

Cell	NULL
87:13	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL

